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
 
A system modelling autophagy is a new area of research. Current understanding 
of each step in this biochemical pathway is limited. The study of this mechanism is 
interesting in several aspects: autophagy plays an important role in physiological 
cellular processes, is a survival mechanism under external stress and is also connected 
with cancer and neurodegenerative diseases [Cuervo, 2004; Kondo et al., 2005; Levine, 
2007; Pan et al., 2008]. 
Autophagy is the pathway for degradation of redundant or faulty cell 
components. This important mechanism occurs in all eukaryotic cells as a part of cell’s 
everyday activities and plays an important role in cell growth and development (cellular 
differentiation, immunity, cellular homeostasis).  
This work proposes a simple mathematical model of autophagy pathway as a 
system with feedback, which controls the level of the total amino acid pool. Feedback 
comes from the amino acids which are produced during the autophagy mechanism 
which is induced as a result of starvation or rapamycin treatment. 
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ABFBA
 
 Autophagy is derived from Greek roots: auto, meaning "self" and phagy – "to 
eat“. It is the pathway for degradation of redundant or faulty cell components. This 
important "housekeeping" complex dynamical system occurs in all eukaryotic cells as a 
part of cell’s everyday activities and plays an important role in cell growth and 
development (cellular differentiation, immunity, cellular homeostasis).  
Autophagy activity is increased in some environmental cases such as a 
starvation, oxygen limitation, and hormonal stimulations or in intracellular stress such 
as microbial invasion, accumulation of mutant proteins and damaged organelles 
[Levine, 2007]. This survival promotion occurs by displacing nutrients from non–
essential to more important processes. This lysosomal degradation system leads to the 
turnover of proteins and organelles. It includes the sequestration of cytoplasm and 
damaged or excess organelles into double–membrane vesicle called autophagosome and 
finally delivery to the lysosome for bulk degradation. Proteins and macromolecules 
destined for degradation during autophagy degrade into amino acids, peptide and fatty 
acids which are reused by the cell for biosynthesis and to fuel energy production. 
Autophagy adapts to stress by escaping from cell death but on the other hand can be an 
alternative path to cellular degradation (type II of PCD, programmed cell death). 
Autophagy is highly regulated by many factors such as amino acids, hormones and 
growth factors [Klionsky, 1999]. 
Paradoxically autophagy plays a dual role in cancer. It depends on the particular 
situation and phase in the pathological process. This system may lead to survival of 
cancer cells and may protect against some of the cancer treatments (ionizing radiation). 
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On the other hand, at early stages of carcinogenesis, autophagy plays a role of a tumor 
suppressor by removing damaged organelles that may generate mutations. Autophagy is 
also involved in the degradation of misfolded and aggregated proteins and therefore 
plays a role in neurodegenerative diseases, such as Huntington’s and Parkinson’s 
diseases. 
 
BBA
Systems biology leads to a better understanding of cellular dynamics by 
investigation the elements of cellular networks and interactions between them. 
Approaches which can be used to achieve these objectives integrate experiments and 
computational modelling. 
Our intension is to develop a mathematical model for the autophagy pathway. 
An attempt to formulate the network of biochemical reactions in a mathematical 
framework can help with better understanding of the lysosomal degradation mechanism. 
In turn, better knowledge of the autophagy pathway could help improve future therapy 
(for example against cancer) and might contribute to recognition of alternative cell 
death mechanisms when some apoptotic pathways are inhibited. Also our work is 
motivated by current uncertainty of the role of autophagy; that is whether autophagy is a 
cell survival mechanism or rather another kind of cell death. Furthermore, the modelling 
might help in the future research to test the hypothesis for connection between 
autophagy and apoptosis, which has been already reported by experimental 
observations. 
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AFBEE
The objective of our work is to identify the molecular control systems regulating 
autophagy in cell death and survival. This is achieved by building mathematical model 
calibrated using published experimental data.  This involves: 
• developing a network of biochemical reactions involved in autophagy pathway, 
• extracting rate expressions and state equations for analysis, 
• simulations, which will be used to predict system behaviour in response to various 
stimuli. 
 
BABA
The main contributions in the thesis: 
• A set of biochemical reactions involved in autophagy induction was extracted based 
on scientific literature reviews. 
• Based on the network of biochemical reactions the set of rate expressions and ODE's 
was developed for computer simulations.  
• Parameters for the simulation were proposed based on experimental literature about 
autophagy and mTOR signalling pathway. 
• First test of an autophagy model was presented and tested. Mathematical model of 
autophagy pathway was detailed as a system with the feedback. 
• The value of the feedback strength was obtained, as well as the autophagy contribution 
on the total amino acid pool during starvation. 
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DAE
This thesis is focused on the study of the dynamics of the autophagy pathway, 
which is involved in controlling of amino acid pool in cells during the starvations 
conditions. Special attention is paid on autophagy induction and reaction which are 
involved in that process.  
Chapter 1 is focused on the introduction to autophagy pathway in general 
meaning. Chapter 2 describes in some details lysosomal degradation mechanisms. It 
explains the role of autophagy in health and diseases and gives an introduction to the 
steps of the autophagy pathway and autophagy related proteins. Also it presents an 
overview of our model from the biological point of view: explains set of reactions 
which are important for mTOR dependent autophagy induction and shows amino acids 
in the feedback loop. Chapter 3 gives an overview of biochemical pathway modelling. It 
presents a few approaches which are used in systems biology, such as the law of mass 
action and Michaelis-Menten kinetics. In the next chapter the dynamical model which 
reproduces the reactions in autophagy induction are presented. It hypothesises a novel 
model structure with references for the individual components of the pathway. It 
includes a diagrammatic representation of the proposed autophagy model, with the 
reactions involved and the ordinary differential equations that represent the system. This 
chapter also presents results of initial simulations. Chapter 5 explains how we extracted 
parameters essential for the model calibration from the experimental literature. The last 
chapter summaries the main results of our work, discuss the potential implications and 
gives some suggestions for future research. 
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 EB! "! C"
 
The balance between cellular biosynthesis and intracellular degradation is 
regulated by two powerful but independent mechanisms: the ubiquitin-proteasome 
system and the lysosome pathway [Korolchuk et al., 2009]. Some cross-talk between 
these pathways has been suggested even though there are many differences in the 
individual mechanisms. These differences include substrate differences (in autophagy 
bulkier and longer half-lives) and time scales (where autophagy is significantly slower 
than the proteasome system) [Korolchuk et al., 2009]. In the other words, autophagy 
degrades long-lived proteins and some cytoplasmic organelles [Onodera and Ohsumi, 
2005], whereas the ubiquitin-proteasome system is involved in the degradation of 
specific short-lived proteins [Yorimitsu and Klionsky, 2005].  
The lysosomal pathway has at least three variants: Cvt (cytosol to vacuole 
targeting) pathway, Vid (vacuolar import and degradation) pathway and autophagy. 
There are three types of autophagy: microautophagy, macroautophagy and chaperone-
mediated autophagy. The most prevalent is macroautophagy. In general autophagy is a 
non-selective process; however in some cases it may select a target. Both types follow 
general steps including autophagosome formation and fusion with the lysosome. During 
non-selective autophagy, autophagic vacuoles enclose bulk cytoplasm. In general, this 
type of autophagy is induced by starvation and leads to increases in the size of the 
vesicle compared with the Cvt pathway. During selective autophagy only particular 
contents are sequestered into a vesicle.  
One classic example of selective autophagy is the cytoplasm-to-vacuole 
targeting (Cvt) pathway, which is a preferential type of transport under normal nutrient 
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conditions. The cytoplasm to vacuole targeting pathway is a biosynthesis transport 
mechanism which delivers Ape1 (aminopeptidase 1) and Ams1 (alpha-mannosidase) 
enzymes to the vacuole. When cells are moved to a poor nutrient medium, the Cvt 
complex (Ape1, Ams1 and Atg19) is wrapped into the autophagosome together with 
other components. Formation of a Cvt vesicle is topologically the same as induced 
autophagy [Baba et al., 1997]. Delivery of organelles or proteins via the Cvt pathway is 
selective and occurs in basal growth conditions while transport by autophagosomes is 
non-selective and is induced by stress [Scott et all, 2000]. Some physiological level of 
autophagy is essential for cellular homeostasis. Excessive levels of autophagy promote 
cell death by digesting vital amounts of cell components while insufficient autophagy 
leads to the accumulation of damaged proteins and organelles. 
The study of the autophagy pathway is interesting in many respects: it plays an 
important role in standard cellular processes, is a survival mechanism under external 
stress and also is connected with cancer and neurodegenerative diseases. In human 
diseases autophagy appears to play the role of a "double-edged sword", where in some 
cases it can mitigate pathogenesis whilst in others, it may aggravate pathologies. 
 
EDAE
Identification of the autophagy pathway started with the discovery of the 
lysosome in 1955 by Christian de Duve [Klionsky, 2007], who subsequently coined the 
name "autophagy", which was introduced in 1963. It was morphologically identified 
first in mammalian cells [Yorimitsu and Klionsky, 2005], however studies with yeast 
have improved knowledge of the molecular mechanism involved in the autophagy 
pathway. In 1992 Ohsumi and colleagues showed that the morphology of this process in 
  
14
yeast was similar to that in mammalian [Takeshige, et al., 1992]. This discovery proved 
very valuable for further studies in autophagy related genes and their orthologs. 
Mortimore and his colleagues demonstrated that amino acids inhibit autophagy and at 
the same time he made a hypothesis that "autophagy could have a physiological role in 
the maintenance of body amino acid pools, although there is no direct experimental 
evidence for this" [Mortimore, 1977; page 174].   
In 1993 the target of rapamycin (TOR) gene was isolated from yeast [Kunz et al., 1993], 
and from mammalians one year later. Shortly after this, the TOR gene was connected 
with protein synthesis, cell growth and cell-cycle progression.  In 1995 Meijer and 
colleagues showed the stimulatory role of rapamycin for autophagy induction 
[Blommaart, 1995]. The same laboratory provided a link between amino acid-dependent 
and TOR-dependent regulation of autophagy pathway by demonstrating stimulation of 
TOR by amino acids. 
In 1966 de Duve suggested that autophagy might be selective process (autophagy still is 
considered to be primarily nonspecific [Kopitz, 1990]). The first evidence for specific 
autophagy of an organelle was showed by Bolender and Weibel in 1973 [Bolender & 
Weibel, 1973]; four years later specific sequestration was demonstrated for 
mitochondria [Beaulaton, 1977], and afterwards for peroxisomes [Veenhuis, 1983]. The 
next example of degradation in a selective manner was the cytoplasm-to-vacuole 
targeting (Cvt) pathway [Harding, 1995]. Its morphology overlaps with non selective 
autophagy, as well as with proteins required [Scott, 1996; Baba, 1997].  
In 1999 B. Levine's laboratory pointed out the essential connection between autophagy 
and diseases [Liang, 1999] and current research demonstrated that defects in autophagy 
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is associated with tumorgenesis [Mathew, 2007] and neurodegenerative diseases 
[Rubinsztein 2005].  
Recent studies have confirmed the hypothesis of Beaulaton and Lockshin, who 
suggested that autophagy is involved in cell death [Beaulaton and Lockshin, 1977]. In 
particular, this shows a connection between programmed cell death (PCD) type I, 
apoptosis, and autophagy (sometimes called type II PCD).  Mostly autophagy acts as a 
cytoprotective mechanism [Boya et al., 2005]. However, if apoptosis is disabled or if 
cellular damage is too large, autophagy may lead to cell death [Boya et al., 2005]. Better 
knowledge of this dual role of the autophagy pathway in cell death and survival is 
crucial for studies in regulation of those mechanisms. A more detailed description of the 
discovery and subsequent identification of the autophagosome process and pathway can 
be found in [Klionsky, 2007]. 
 
B! "#ABA
Autophagy plays a significant role in adaptation to starvation, development 
(birth, sporulation, fruiting body formation – for more details see Mizushima, 2005), 
programmed cell death, intracellular protein and organelle removal, elimination of 
microorganisms (degradation of bacteria), anti-aging, tumor suppression and prevention 
of neuron degradation [Xie and Klionsky, 2007; Mizushima, 2007]. This mechanism is 
an effective degradation process which can turn over proteins and remove redundant 
organelles. 
In some cases is very difficult to determine the role of autophagy, for example in 
cancer (see section 2.6) and cell survival and cell death (see section 2.5). Subclassifying 
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autophagy into "basal" (Cvt pathway) and "induced" might be helpful to better 
understand the various roles of autophagy. However, the normal (or basal) level of 
autophagy is low; however, it can be upregulated by starvation (birth and fasting). The 
basal level of autophagy is essential for intracellular quality control while the induced 
autophagy – for intracellular production of amino acids during nutrient deprivation 
[Mizushima, 2005]. 
 
$E!B# EB! "! C"
The key steps in the autophagy process are:  
1) Induction of autophagy,  
2) Nucleation of phagophore, 
3) Vesicle expansion and completion,  
4) Retrieval of Atg9 from the PAS,  
5) Targeting, docking and fusion with the lysosome,  
6) Breakdown of the autolysosome,  
7) Recycling of the macromolecular constituents. 
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Figure 2.3 Steps of autophagy. At the beginning of the autophagy pathway creation of 
the phagophore/isolation membrane is observed (vesicle nucleation). In the next step 
Atg proteins are involved which are responsible for vesicle expansion. The 
autophagosome sequesters a bulk cytoplasm with organelles. The outer membrane fuses 
with a lysosome and creates an autophagolysosome. Finally, wrapped material 
undergoes breakdown and recycling   [Taken from Melendez and Levine, 2009]. 
 
Each step requires many of the autophagy related proteins Atg. For further information 
about autophagy related proteins which are essential for lysosomal degradation 
pathway, see sub-chapter 2.4. 
 
2.3.1 Induction of autophagy 
During the normal vegetative nutrient conditions autophagy occurs at a basal 
level in yeast and mammalians. mTOR (mammalian target of rapamycin) is a master 
controller of nutrient and growth factors signalling, which suppress autophagy induction 
under nutrient-rich conditions.  
mTOR signalling strongly regulates the binding between Atg1 and Atg13. The active 
form of TOR, in nutrient – rich conditions, affects hyperphosphorylation of Atg13, 
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which inhibits its association with Atg1 [Kamada et al., 2000]. After rapamycin 
treatment or during starvation (which is a classical inductor of the autophagy pathway) 
TOR activity is repressed and this causes rapid dephosphorylation of Atg13. This form 
of Atg13 has a high affinity for Atg1. This binding activates Atg1 kinase and leads to 
induction of autophagy.  
Atg1 creates a complex with Atg13, Atg17 and Cvt9. All of the proteins are 
found to play a role in either the Cvt pathway or autophagy, but not both as Atg1. For 
example the Atg1-Atg13 association is essential for autophagy but not for a Cvt 
pathway. This suggests that the Atg1 complex acts as a switching point between two 
distinct pathways for targeting proteins in response to nutrient conditions.  
 
Figure 2.3.1 Autophagy induction by TOR inhibition. In rich nutrients conditions that 
support transport via the Cvt pathway, Atg13 is hyperphosphorylated. In starvation 
autophagy pathway is induced by switching complex Atg1-Atg13.  [Taken from 
Gozuacik and Kimchi, 2004]. 
 
In mammalian cells, in response to ligand binding to the receptor (for example 
InR insulin receptor), a class I PI 3-K (class I phosphoinositide 3-kinase) is stimulated. 
Creation of the PtdIns(3)P (phosphatidylinositol 3-phosphate) at the membrane allows 
the attaching and activation of PDK1 (3-phosphoinositide-dependent protein kinase 1) 
and Akt/PKB (protein kinase B). Afterwards inhibition of TSC complex, which is a 
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GTP-ase activating protein for the Rheb (see chapter 2.7.2), by Akt resulting in the 
stabilization of the GTP-bounded form of Rheb. This form activates TOR and as a result 
– inhibits induction of autophagy [Klionsky, 2005]. For more detailed discussion of 
mTOR activation see chapter 2.7. 
 
 
Figure 2.3.2 Regulation of autophagy induction in mammalian cells. In higher 
eukaryotes, regulation of TOR is mediated via the action of a PI 3-K. Description of the 
roles of particular elements from the diagram see text above [Taken from Klionsky, 
2005]. 
 
2.3.2 Vesicle nucleation and autophagosome formation 
In yeast the location for autophagosome formation is called the pre-
autophagosomal structure or the phagophore assembly site (PAS) [Xie and Klionsky, 
2007; Mizushima, 2008]. The PAS is a composite of the forming vesicle and the core 
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machinery proteins which lead to the process of expansion and transformation of the 
phagophore into an autophagosome.  
The mechanism involved in vesicle formation and the genesis of the 
autophagosome membrane are not well known. In one of the model a vesicle is 
produced from pre-existing organelle (for example ER) by budding. The new-created 
vesicle has the same cellular topology as the membrane donor. Another model assumes 
that the vesicle is formed de novo [Klionsky, 2005].  
 
2.3.3 Vesicle expansion and complexion 
Most of the proteins which are involved in autophagy pathway appear during 
vesicle formation. Vesicle expansion and completion are parts of this process.  
The proteins that perform in the vesicle expansion and completion create two 
sets of ubiquitin-like (Ubl) proteins: Atg8-PE (phosphatidylethanolamine) and Atg12-
Atg5 [Yorimitsu and Klionsky, 2005]. Both of these proteins localize at the PAS. 
At the beginning of the conjugation, Atg8 undergoes cleavage by Atg4 protease. This 
process results in removing arginine residue (R) from Atg8 to expose a glycine residue 
and converts a soluble Atg8 to a membrane-associated protein. The conjugation system 
requires an ubiquitin-activating E1-like enzyme, Atg7. Atg8, even as Atg 12 from the 
second conjugation system, is activated by Atg7. Afterwards, Atg8 and Atg12, via the 
action of an E2-like conjugating enzyme (Atg3 for Atg8 and Atg10 for Atg12), are 
attached to the PE (phosphatidylethanolamine) and Atg5, respectively. Next Atg12-
Atg5 complex attaches Atg16 and all form a tetrameric complex, while Atg8-PE docks 
  
21
to the PAS. In the complete vesicle Atg8 is released from membrane by Atg4 cleaving 
[Klionsky, 2005]. 
 
 
Figure 2.3.3 Atg proteins involved in vesicle expansion and completion. Two 
ubiquitin-like proteins act in the process. For detailed description see text above 
[Klionsky, 2005]. 
 
2.3.4 Retrieval of Atg9 
In most cases Atg proteins present a single localization at the PAS but Atg9 and 
Atg23 are also delivered to the many another structures. The movement of the Atg9 
between PAS and non-PAS structures is crucial for autophagosome formation [Xie and 
Klionsky, 2007]. The Atg9 transport factors (Atg23 and Atg27) are responsible for 
effective transfer of Atg9 to the PAS. The retrieval of Atg9 from the PAS involves Atg1 
complex, Atg2 and Atg18.  
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Figure 2.3.4 PAS. Different proteins are localized in the PAS, depending on the phase 
of the vesicle formation. a) The PI(3)K complex: the lipid kinase Vps34, the enzyme 
Vps15 and Atg6. b) The position of Atg2 and Atg18 at the PAS depends on Atg9, Atg1, 
the PI(3)K complex and on each other. c) The cycling of Atg9 between PAS and the 
peripheral site. Effective delivery to the PAS requires Atg9 transport factors (Atg23 and 
Atg 27) while away from the PAS Atg18, Atg1 complex andAtg2 are involved [Taken 
from Xie and Klionsky, 2007]. 
 
Based on figure 2.3 the retrieval Atg9 from the PAS has three stages: 
a) Atg9 and Atg1 complex are gathered to the PAS 
b) Atg18 and atg2 are recruited to the PAS where they interact with Atg9 
c) Atg9 moves out from the PAS. 
The probable function of Atg9 cycling is to provide lipids for autophagosome formation 
[He et al., 2006]. 
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2.3.5 Fusion with a lysosome 
The vesicle fusion with the lysosome must be controlled to prevent premature 
fusion. The complex of Atg12-Atg5-Atg16 and Atg8-PE, placed on the outer membrane 
of autophagosome, regulate the fusion process [Klionsky, 2005]. 
The proteins system required for fusion process include: the SNARE proteins (Vam3, 
Vam7, Vti1 and Ykt6), the NSF, SNAP and GDI homologs (Sec17, Sec18 and Sec19), 
the Rab protein Ypt7, members of the class C Vps/HOPS complex, proteins Ccz1 and 
Mon1 [Klionsky, 2005].  
 
2.3.6 Breakdown of the autolysosome and recycling 
After fusion autophagosome with the lysosome (or vacuole in yeast), the inner 
membrane of the autophagosome and its contents (cytoplasmic material) are degraded 
by lysosomal/vacuolar hydrolases [Mizushima, 2008]. This step of autophagy pathway 
depends on the acidic pH of the vacuole. Also Atg15 and Atg22 may be involved in the 
breakdown step.  
Thereafter proteins and macromolecules are degraded in the lysosome/vacuole 
into simple elements (amino acids, peptide and fatty acids) which are exported to the 
cytosol for reuse by cell for biosynthesis of essential components and to fuel energy 
production. Amino acids produced via autophagy can be oxidized to produce energy in 
some tissues (such as muscles) or used for synthesis of proteins that are essential for 
adaptation to starvation [Mizushima, 2005]. 
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The ATG genes encode proteins essential for all steps involved in autophagy 
pathway. There are four functional groups of Atg proteins [Levine and Junying, 2005; 
Xie and Klionsky, 2007]: 
A) protein serine/threonine kinase complex which responds to TOR kinase (Atg1, 
Atg13, Atg17);  
B) lipid kinase signalling complex PI(3)K which induces vesicle nucleation (the 
PI(3)K complex is formed by Atg6/Vps30, Atg14, Vps34/class III PI(3)K and 
Vps15 and is localized to the PAS);  
C) two ubiquitin-like Ubl protein conjugation system, Atg12 and Atg8, which 
are essential for vesicle expansion and completion (includes an E1-like 
activating enzyme Atg7, two E2-like conjugating enzymes Atg10 (for Atg12) 
and Atg3 (for Atg8), an Atg8 modifying protease Atg4 (cause releasing PE from 
Atg8-PE), Atg5 and Atg16);  
D) a retrieval pathway, Atg9 and its cycling system, involved in disassembly of 
Atg proteins from matured autophagosome (Atg9, Atg1-Atg13 complex, Atg2, 
Atg18).  
 
For more detailed description of the core proteins required for autophagy and PAS see 
Xie and Klionsky, 2007. 
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Apart from classical apoptosis, there are several types of programmed cell death 
(PCD). Nomenclatures "autophagic cell death" or "type II cell death" are used for a 
mechanism characterized by the presence of autophagolysosomes. A term "autophagy" 
is preferred when describing a degradation process rather than cell death. However, for 
this type of death the most adequate terminology is "cell death with autophagy" 
[Mizushima, 2005]. The role of autophagy is quite controversial and creates question 
whether autophagy is a cell death or a survival mechanism. Recent studies suggest that 
autophagy can mediate cell death [Yu et al., 2004; Shimizu et al., 2004] and conversely 
it can also act as a cytoprotective mechanism during starvation [Lum et al., 2005]. 
Furthermore, inhibition of autophagy triggers starvation-induced apoptosis [Boya et al., 
2005]. For that reason, the role of autophagy as a cell death executor or cell protector 
might be connected with cellular nutrient conditions [Mizushima, 2005]. 
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Figure 2.5. A motif function of autophagy. Activation of signalling pathways that 
induce utophagy by metabolic stress and anti-cancer treatment. Dual role of 
autolysosomal degradation of cytoplasmic material: cell survival (generating fatty acids 
and amino acids for reuse and by removing harmful organelles and proteins) and cell 
death (self-cannibalisation). Also the turnover of proteins and organelles by autophagy 
can contribute to the control of cell growth [Levine, 2007]. 
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Autophagy is linked to several human pathologies, such as different kinds of 
cancer, Parkinson's disease and Alzheimer's disease [Cuervo, 2004; Kondo et al., 2005; 
Levine, 2007; Pan et al., 2008]. A better understanding of the role of autophagy in 
diseases is a great recent research interest; therefore the topic of lysosomal degradation 
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is developing very fast nowadays. Autophagy has been reported as a survival 
mechanism but also as a cell death, depending on the progression of the disease, the 
cellular surroundings and therapeutic treatment [Cuervo, 2004]. 
 
2.6.1 Neurodegenerative diseases 
A hallmark of several neurodegenerative diseases, such as Parkinson's disease, 
Alzheimer's disease and Huntington's disease, is intracellular protein aggregates which 
contain mutant proteins. Induction of autophagy may be beneficial for removing those 
aggregates, while inhibition causes formation of them [Mizushima, 2005]. The main 
challenging question in the topic of neurodegeneration diseases is how to prevent or at 
least slow down the formation of aggregates by promoting the turnover of misfolded 
proteins. For more information about protein aggregations and neurodegenerative 
diseases see Cuervo, 2005. 
 
2.6.2 Cancer 
The evidence which linked cancer and autophagy results in greater interest in the 
topic of autophagy pathway. Better understanding the role of autophagy in individual 
stages of tumor development may lead to improvement of anticancer treatment. 
Induction as well as inhibition of autophagy may enhance and inhibit 
progression and development of tumor. The relationship between autophagy regulation 
and tumor progression depends on the particular situation and phase in the pathological 
process. In typical cancer cells, due to autophagy suppression, protein synthesis prevails 
over degradation and cellular growth remains. Down-regulation of autophagy may 
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cause accumulation of toxic biochemical species that might stimulate mutation and 
support tumorgenesis [Cuervo, 2004].  Therefore, at early stages of carcinogenesis, 
autophagy plays a role of a tumor suppressor.  
On the other hand, tumor cells in late states of development are often low in 
nutrient factors and oxygen, and therefore may require autophagy for continued growth. 
For this reason autophagy can be induced to assure survival of tumor cells under 
adverse circumstances, for example, the inner area of tumor, with low vascularisation. 
To compensate for the low supply of nutrients and oxygen, activation of autophagy 
helps to gain the materials for the synthesis of the essential components by degradation 
of unnecessary intracellular elements. Furthermore induction of autophagy is beneficial 
in some type of cancers as a response to radiation and chemotherapy – it helps eliminate 
damaged structures before they accumulate, thereby reducing the desired death rate of 
tumor cells. 
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Figure 2.6 Double role of autophagy in cancer. Depending on the stage of tumor 
development, both inhibition and activation of autophagy may be beneficial for cancer 
cells. a) In the early stages, decreased autophagy leads to increasing protein synthesis 
and cellular growth. b) In the late stages, increased autophagy may help to survival of 
the cells located in centre of the tumor, which have restricted access to nutrients and 
oxygen. Furthermore, induced autophagy may be a defensive system as a response to 
different anticancer treatment. [Taken from Cuervo, 2004]. 
 
The conflicting pro-survival and pro-death autophagy performing makes the 
cancer treatment more complex. Efficacy of anticancer therapeutic may be improved by 
manipulation of autophagy [Kondo et al., 2005]. 
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The mammalian target of rapamycin (mTOR) is a serine/threonine kinase which 
is highly conserved in all eukaryotes. During the nutrient rich conditions mTOR occurs 
in a active form and controls many processes that are involved in cellular growth and 
metabolism in response to growth factors stimulations (insulin – via the PI3K-Akt/PKB 
pathway – figure 2.7.1), changes in cellular energy levels (ATP) and nutrients 
sufficiency (amino acids) – and in turn plays a role of a nutrient status sensor [Zempleni, 
2005; Meijer, 2008]. mTOR also acts as a gatekeeper for autophagy induction. 
Inactivation of mTOR by starvation or rapamycin treatment causes dephosphorylation 
of Atg13. This in turn raises the affinity Atg13 to Atg1 and this association results in 
increasing Atg1 protein kinase activity [Meijer, 2008]. For more detailed discussion 
about autophagy induction see chapter 2.3.1 and references Kamada et al., 2000 and 
Klionsky, 2005. 
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Figure 2.7.1 The mTOR signalling network [taken from Hall, 2008]. 
 
A lack of growth factors and energy can be repaid by high level of amino acids, 
but not vice versa [Hall, 2008]. This means that amino acids are a strong signal which 
positively regulates mTORC1 [Laplante and Sabatini, 2009]. An essential amino acid 
necessary for mTORC1 activation, as it was recently shown, is leucine. mTOR controls 
cell growth by both positively (protein synthesis, mitochondrial metabolism) and 
negatively (autophagy, apoptosis) regulating processes.  
 
2.7.1 Complexes of mTOR: mTORC1/mTORC2 
mTOR remains in two signalling muliprotein complexes: mTOR complex 1 
(mTORC1) and mTOR complex 2 (mTORC2). mTORC1 is composed of mTOR, raptor 
  
32
(regulatory associated protein of mTOR), mLST8/GL protein, PRAS40 [Vinod and 
Venkatesh, 2009; Kim, 2009] and FKBP38 [Kim, 2009; Bai et al., 2007]. This complex 
controls protein synthesis and functions as a nutrient/energy sensor. The activity of 
mTORC1 is stimulated by insulin, growth factors, amino acids and oxidative stress, 
while inhibition is caused by nutrient deprivation, low growth factor levels and 
rapamycin. Complex 1 is called a rapamycin-sensitive complex. mTORC2 is composed 
of mTOR, Rictor (rapamycin-insensitive companion of mTOR), mLST8/GL and 
mSIN1. mTORC2 is regulated by insulin and growth factors. Complex 2 is called a 
rapamycin-insensitive complex. For more information recommended further reading: 
Bai and Jiang, 2009; Laplante and Sabatini, 2009. 
 
2.7.2 mTOR activation 
The mechanism by which amino acids activate mTORC1 is not well known yet. 
Some of the research results suggested that upstream of mTOR are TSC1-TSC2 and 
small GTPase Rheb. Recently, Rheb was confirmed as an effector of the TSC1/TSC2 
complex. TSC complex directly interacts with Rheb [Bai and Jiang, 2009] and 
modulates its GTP hydrolysis activity. Some evidence shows that Rheb is regulated by 
amino acids conditions [Roccio et al., 2005] when depletion of amino acids reduces the 
levels of GTP-bounded Rheb.  
FKBP38, by directly binding to mTOR [Bai and Jiang, 2009], inhibits activity of 
mTORC1 [Bai et al., 2007].  The level of cytosolic FKBP38 is negatively correlated 
with the mTOR activity [Bai and Jiang, 2009]. The interaction FKBP38 with mTOR is 
controlled by Rheb, which inhibits its association by directly binding to FKBP38 [Bai et 
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al., 2007] – see figure 2.7.2. Rheb-FKBP38 binding is GTP-dependent [Bai and Jiang, 
2009].  
 
 
Figure 2.7.2 A model for the role of FKBP38 in mTORC1 regulation. FKBP38 by 
direct binding to mTOR inhibits its activity. Rheb, in GTP-bounded form, interacts with 
FKBP38 and allow activation of mTORC1. TSC1/TSC2 complex promotes the 
hydrolysis of GTP to GDP.  [Taken from Bai and Jiang, 2009]. 
 
The association of Rheb with FKBP38 in cells is controlled by amino acids and growth 
factors and in starvation conditions it seems to be a weak binding [Bai and Jiang, 2009].  
 
2.7.2.1 Rheb 
Rheb (Ras-homology enriched in bran) is a small GTPase which is structurally 
close to Ras. The regions involved in GTP binding in Rheb are similar to those in Ras 
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and it is believed that the core action mechanism of Rheb is similar to Ras [Bai and 
Jiang, 2009]. There is one difference (Rheb contains an arginine, not a glycine like 
Rheb at the homologue position) which results in a high level of GTP-bound Rheb in 
cell. 
The activity of the small GTPases depends on their nucleotide-binding states, which are 
controlled by their related GAPs (GTPase-activating protein) and GEFs (guanine 
nucleotide exchange factor). The GAP for Rheb is TSC1/TSC2 complex, which 
stimulates GTP hydrolysis. Recently TCTP (the translationally controlled tumor 
protein) has been suggested to be the GEF for Rheb [Bai and Jiang, 2009]. 
 
2.7.2.2 FKBP38 
FKBP38 belongs to the PPIase (peptidyl prolyl cis/trans isomerase) family of 
FK506-binding protein. It has been suggested to be an inhibitor of mTOR [Bai et al., 
2007] and its level was found in reverse relation with mTOR1 activity. It is a part of 
mTORC1 complex [Kim, 2009; Bai et al., 2007]. FKBP38 is structurally related to 
FKBP12 and it inhibits mTOR activity by binding to it, in a similar manner to the 
FKBP12-rapamycin complex [Bai et al., 2007]. 
 
2.7.2.3 GTPase switch proteins 
In signal transduction pathways we can observe a group of intracellular switch 
proteins, which belong to the GTPase superfamily. The GTPase switch proteins occur in 
two forms: in active "on" GTP-bounded form and inactive "off" GDP-bounded form. 
GTP-bounded form modulates the activity of specific proteins [Lodish, 2001].  
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Figure 2.7.3 Cycling of GTPase switch proteins between the active and inactive forms 
[Lodish, 2001]. 
 
GAP (GTPase-activating protein) – promotes hydrolysis of bounded GTP to GDP; 
TSC1/TSC2 is a GAP for Rheb [Laplante and Sabatini, 2009]. Opposite reaction is 
catalyzed by GEF (guanine nucleotide exchange factor) and TCTP has been suggested 
to be the GEF for Rheb. 
During the signal deficiency, the protein is bound to GDP, whereas signals activate the 
release of GDP and binding to GTP. For more detailed discussion see "Molecular cell 
biology" [Lodish et al., 2001]. 
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Amino acids are essential to life and have a variety of roles in metabolism. One 
particularly significant function is to building blocks of proteins. Also they are 
prominent as precursors for the biosynthesis of molecules and in many other metabolic 
pathways [Murray, 2003]. Due to their central role in biochemistry, amino acids are 
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very important in nutrition. Nutrients must be taken in from an environment in the shape 
of food (for human and animals) or nutriment (for cell culture). 
Beside those functions, amino acids also play a role of signalling molecules that 
control signal transduction pathways [Meijer, 2008]. mTOR-dependent signalling 
pathway is activated by amino acids (especial leucine) in synergy with insulin. 
Induction of this pathways results in suppression of lysosomal degradation pathway and 
amino acids are known as inhibitors of autophagy. 
All organisms use many metabolic changes to survive during nutrient shortage 
periods. One of them is the autophagy pathway, where cells degrade their intracellular 
contents to support essential functions. Onodera and Ohsumi have shown that protein 
synthesis under nitrogen starvation requires autophagy and the products of degradation 
via autophagy are essential for this biosynthesis [Onodera and Ohsumi, 2005]. This 
suggestion of the amino acids in a feedback loop from protein degradation and back to 
building processes is used in our initial model, in chapter 4. During cellular starvation 
without autophagy the free amino acid pool decrease dramatically and could be limited 
as a substrate for protein synthesis. Next they showed that autophagy is fundamental for 
the maintenance of a free amino acid pool under starvation. Without autophagy, many 
of the amino acids fall below critical levels. 
Autophagy may be inhibited by the insulin-amino acid-mTOR signalling 
pathway (figure 2.8.1) and can be activated by amino acids depletion or rapamycin 
[Meijer and Codogno, 2008]. Insulin, in synergy with amino acids, inhibits autophagy 
by activating mTOR, which results in the phosphorylation of the protein kinase Atg13 
and inhibition of its association with Atg1. Complex of Atg1 and Atg13 is essential for 
induction of autophagy. 
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Figure 2.8.1 Regulation of autophagy by insulin and amino acids. Amino acids in a 
feedback loop. Activation of mTOR requires input from amino acids and insulin, which 
next stimulates protein synthesis and phosphorylates Atg13, which results in inactive 
form of Atg1. Amino acids, which are the products of autophagy pathway, play a role of 
feedback regulator for the process [Yang et al., 2005; figure taken from Meijer and 
Codogno, 2008]. 
 
2.8.1 Mechanism of amino acids sensing in mTOR-mediated signalling 
Amino acids can regulate autophagy via modifications in the signalling 
pathways activity.  The main question is how the level of amino acids is sensed and 
signals to mTOR (figure 2.8.2). Amino acids are provided into the cell via amino acid 
transporters. Currently few mechanisms of amino acid sensing are proposed, but recent 
studies suggest that intracellular amino acid concentration is responsible for the control 
of mTOR signalling pathway (intracellular amino acid receptor), rather than a 
membrane amino acid transporter [Kim, 2009]. 
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Figure 2.8.2 Mechanisms of amino acid sensing by mTOR. Amino acids may activate 
mTORC1 by membrane sensor or intracellular amino acid sensor [Kim, 2009]. 
 
Nutrients conditions regulate mTORC1 activity, despite the mechanism is not 
well known. Amino acids inhibit TSC1/2 complex and that could be one of the 
mechanisms for intracellular amino acid sensing. Another study suggests that amino 
acids stimulate the binding of Rheb with mTOR.  Rheb activates mTORC1 by binding 
to mTOR via FKBP38 and this association is reduced when amino acids are depleted. It 
could be proposed that mTOR itself is the amino acid sensor – then the effect of 
nutrients is indirect and amino acids could lower the concentration of an inhibitor which 
is involved in with the Rheb-mTOR association [Meijer, 2008]. For more detailed 
information of the mTOR activation see chapter 2.7.2. 
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This section describes some simple ideas of biochemical pathway modelling and 
approaches which are used in systems biology. A main target of systems biology is to 
turn a biochemical reactions networks maps into dynamic models. Using mathematical 
analysis or computer simulations, these models can enhance the knowledge of 
biochemical mechanisms, help to understand of dynamical interactions between 
components and also can predict behaviour of the system in response to different kinds 
of stimuli. 
Several modelling approaches for biochemical reactions or networks have been 
used to study metabolic networks and signalling cascades [Klipp, 2005]. Models of 
signalling cascades are often based on ordinary differential equations (ODE). According 
to Huber, they are "so far probably the most successful mathematical approaches to 
describe the molecular dynamics during cell death signalling" [Huber et al., 2009]. 
ODE models describe the fluctuation of states and assume a spatial homogeneity of 
distribution of the components within the modelled cell. They contain all biochemical 
reactions that can take a part in the modelled network and the relevant reaction rates and 
kinetic constants that characterize relations between reactants and products. 
In this section we describe kinetic modelling of individual biochemical 
reactions. The elementary quantity expressions are: 
a) the concentration S of a substance S (number of the molecules per volume) 
b) the reaction rate  (change of concentration S per time). 
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In biochemical kinetics we take advantage of assumption that "the reaction rate  at a 
certain point in time and space can be expressed as a unique function of the 
concentrations of all substances at this point in time and space" [Klipp, 2005]. 
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Kinetics of the biochemical reactions is based on the mass action law, proposed 
in 1864 by Guldberg and Waage. It says that "the reaction rate is proportional to the 
probability of a collision of the reactants. This probability is in turn proportional to the 
concentration of reactants to the power of the molecularity, i. e., the number in which 
they enter the specific reaction" [Klipp, 2005]. 
In signalling networks most reactions are modelled using the law of mass action. Other 
approach used in systems biology is a Michaelis – Menten kinetic.  
Based on some elementary biochemical reactions and on mass action kinetic, here are 
basic examples for ODE generation: 
a) Binding/Dissociation: 
This reaction is reversible and in biochemical sense it means protein synthesis (for 
example inhibitor – target interaction).  
Consider the following reaction where A and B react to form a complex AB: 
                                                           ABBA
k
k
1
1−
↔+                                                    (3.1.1) 
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According to the law of mass action the reaction rate v  is proportional to the product of 
the reactant concentrations: 
                                           1 1k A B k ABυ υ υ+ − −= − = ⋅ ⋅ − ⋅                                       (3.1.2) 
where: 
υ+  forward reaction 
υ
−
 backward reaction 
11 , −kk  kinetic/rate constants. 
We can describe the temporal change in concentration of the proteins and the complex 
using the ordinary differential equations:  
                                       1 1
dA dB k A B k AB
dt dt
υ
−
= = − = − ⋅ ⋅ + ⋅                                   (3.1.3) 
                                              1 1
dAB k A B k AB
dt
υ
−
= = ⋅ ⋅ − ⋅                                       (3.1.4) 
 
b) Irreversible cleaving: 
                                            
'''2 CCACA k ++→+                                                (3.1.5) 
This reaction is irreversible and in a biochemical sense it can be analysed as an enzyme 
A, without being changed itself, cleaving protein C into two fragments C' and C'' and 
returning the enzyme.  
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From the law of mass action, reaction rate is: 
                                                         2k A Cυ = ⋅ ⋅                                                      (3.1.6) 
Based on this reaction we can illustrate the dynamic of the concentrations of reactants 
using ODEs: 
                                                      2
dC k A C
dt
= − ⋅ ⋅                                                    (3.1.7) 
                                                      0dAA const
dt
=  =                                             (3.1.8) 
                                                  
' ''
2
dC dC k A C
dt dt
= = ⋅ ⋅                                              (3.1.9) 
 
c) Degradation: 
                                                         0→kA                                                        (3.1.10) 
The kinetics of this simple decay can be described by reaction rate: 
                                                          Ak ⋅=υ                                                         (3.1.11) 
The dynamic of the concentration of substrate A can be illustrated by ODE: 
                                                          Ak
dt
dA
⋅−=                                                    (3.1.12) 
 
The ODE’s integration from time t=0 and initial concentration A0, to time t with 
concentration A(t) leads to the expression: 
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tkeAtA ⋅−⋅= 0)(                                                (3.1.13) 
The equation 3.1.13 formulates that the quantity decreases at a rate proportional to its 
value. 
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In 1902 Brown introduced the first enzymatic mechanism which was for all one-
substrate reactions [Klipp, 2005]: 
                                               PEESSE k
k
k
+→↔+
−
2
1
1
                                           (3.2.1) 
The reaction illustrates a reversible formation of the enzyme-substrate complex ES from 
the enzyme E and substrate S and irreversible deliver of the product P. The systems of 
ODEs for this reaction are: 
                                                ESkSEk
dt
dS
⋅+⋅⋅−=
−11                                          (3.2.2) 
                                          ESkkSEk
dt
dE
⋅++⋅⋅−=
−
)( 211                                     (3.2.3) 
                                         ESkkSEk
dt
dES
⋅+−⋅⋅=
−
)( 211                                       (3.2.4) 
                                                       ESk
dt
dP
⋅= 2                                                       (3.2.5) 
The reaction rate is equivalent to the rate of decay of the substrate and of product 
formation: 
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dS dP
dt dt
υ = − =                                                        (3.2.6) 
 
To simplify the ODE system some assumptions can be made:  
a) the transformation of the enzyme E and substrate S to ES complex and the 
opposite reaction is much faster than the decay of ES complex into enzyme E 
and product P (quasi-equilibrium between the free enzyme and the ES complex). 
In terms of the kinetic constants this assumption can be expressed as:  
                                             211 , kkk >>−                                                      (3.2.7) 
b) to reached a steady state the ES complex has to remain constant and this 
condition is accomplished only if the initial concentration of the substrate S is 
much larger than the concentration of enzyme E: EtS >>= )0( ; the more 
general postulate of quasi-steady state of the ES complex: 
                                                  0=
dt
dES
                                                  (3.2.8) 
The reaction rate can be extract by using above ODEs (3.2.2-3.2.5) and the assumption 
(3.2.8) for ES. Adding (3.2.3) and (3.2.4): 
                                                        0=+
dt
dES
dt
dE
                                                   (3.2.9) 
results in: 
                                                        ESEEtotal +=                                                 (3.2.10) 
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what means that total concentration of enzyme, free form or in complex, remains 
constant – enzyme is not produced and not consumed. 
Adding equation (3.2.10) to (3.2.4) under the steady-state assumption (3.3.8): 
                                                 
1
21
k
kkS
SE
ES total
+
+
⋅
=
−
                                                 (3.2.11) 
and the reaction rate from (3.2.6) and (3.2.5): 
                                            
2
2
1 2
1
totalk E Sk ES k kS
k
υ
−
⋅ ⋅
= ⋅ =
+
+
.                                           (3.2.12) 
Above equation we can write in shorter way, using: 
                                                    totalEkV ⋅= 2max                                                    (3.2.13) 
                                                      
1
21
k
kk
K m
+
=
−
                                                   (3.2.14) 
where: 
maxV  is the maximal velocity – maximal ratio that can be obtained when the enzyme is 
completely saturated with substrate; 
mK  is the Michaelis constant – is equivalent to the substrate concentration that 
produces the half-maximal reaction rate. 
Now we can present equation (3.2.12) as an expression of Michaelis-Menten kinetics: 
                                                       
mKS
SV
v
+
⋅
=
max
                                                      (3.2.15) 
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The figure below shows the dependence of reaction rate on substrate concentration, and 
helps illustrate the meaning of the parameters: 
 
 
Figure 3.2.1 Plot of reaction rate versus substrate concentration in Michaelis-Menten 
kinetics [taken from Klipp et al., 2005]. 
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Feedback loops are the principal elements for all kind of regulation and control. 
In general, when a variable of a system inhibits its own level of activity, we say that this 
variable is subject to negative feedback. Negative feedback plays an important role in 
metabolic pathways, for example in amino acids synthesis, where a negative signal from 
the product at the end to the precursor at the beginning of the system can avoid an 
overproduction of this amino acid [Klipp, 2005]. Another example is a product of a 
gene which inhibits its own gene.  
To illustrate some possible effects of negative feedback let's analyze a chain of six 
reactions with a substrate, five metabolites and final product: 
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61 2
0 1 2 5 6...
vv vP S S S P←→ ←→ ←→                                   (3.3.1) 
for which kinetics rate expressions is 1i i iv S k−= ⋅  for  1,...,6i = , where ik corresponds to 
kinetics constant of i -th metabolite. 
Feedback inhibition of the first reaction by the j -th metabolite is: 
                                                     
1 1
1 1 j I
S k
v
S K
⋅
=
+ ⋅
                                                      (3.3.2) 
where IK corresponds to inhibition constant. 
In the case of no feedback, all substrates concentrations reach a steady state in 
short time (see figure 3.4.1). 
 
Figure 3.4.1 The dynamics of a simple reactions chain. In the absence of feedback, all 
metabolite concentrations reach asymptotically a high constant level [Klipp, 2005]. 
 
In the case when the feedback is from the second metabolite, the substrate 
concentrations reach a steady state but in significant lower level. 
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Figure 3.4.2 The dynamics of a simple reactions chain. The second metabolite inhibits 
the first reaction [Klipp, 2005]. 
 
In final example, when feedback is from the last metabolite resulting on 
inhibition of the first reaction, concentrations of substrates reach lower level than 
without feedback. A long acting feedback results in damped oscillations. 
 
 
Figure 3.4.3 The dynamics of a simple reactions chain. The long acting feedback 
creates damped oscillations and the level of substrate concentrations reach lower than 
without feedback steady state [Klipp, 2005]. 
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We propose a simple model of amino acid control in the cell via autophagy as 
the feedback system. The idea behind our model is based on literature which show 
amino acids in the feedback loop from degradation of proteins and back to building 
proteins. According to Yang, "Amino acids, which are the final products of autophagic 
protein degradation, act as negative feedback regulators for the process" [Yang et al., 
2005]. In other words, the products of degradation via autophagy are essential for 
protein biosynthesis in nutrient limitation [Onodera and Ohsumi, 2005]. 
A brief description of the model is provided in this chapter, with biochemical 
reactions, mass balances, and kinetic equations and models parameters. 
Chapter 4 describes mathematical modelling based on ODEs. In this part of the 
thesis we focus on the mTOR dependent induction of autophagy which occurs as a 
response of cells to amino acid depletion. A simplified version of autophagy induction 
is described by four reactions (R1, R3, R5 and R6). This model also trades on idea of 
amino acids from autophagy in a negative feedback to control level of total amino acid 
pool. We use here idea of time delay for the part of the pathway from autophagosome 
nucleation to degradation in lysosome and recycling. 
Reactions involved in the induction of autophagy are complex. Autophagy can 
be initiated by many different interacting pathways (see figure 2.7.1, chapter 2): 
changes in cellular energy levels, nutrients availability and in response to growth factors 
stimulations. One of the main regulators of autophagy is the level of extracellular and 
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intracellular amino acids, which are sensed via mTOR. mTOR in an activated form 
promotes protein synthesis. Active mTOR keeps in hyperphosphorylated state Atg13, 
thus inhibits the induction of autophagy. Stressor signals, like starvation, inhibit mTOR 
activity and in turn induce autophagy. Autophagy also can be activated by intracellular 
debris (unfolded proteins and damaged organelles) and pathogens. 
  
To simplify our work with autophagy model we start by modelling the mTOR – 
dependent pathway which is controlled via amino acid signalling and it involves: signal 
from amino acid external supply and from autophagy, Rheb, FKBP38, mTOR, Atg13 
and Atg1. The diagram below displays connections between those elements. 
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Figure 4.1 Diagram of the autophagy induction. Diagram was made based on 
scientific literature about autophagy pathway. It shows mTOR-dependent autophagy 
induction, which includes amino acid external supply, Rheb, FKBP38, mTOR, Atg13 
and Atg1. 
 
The mTOR is a fundamental cell growth controller and its activity is regulated 
by Rheb in response to nutrient availability and growth factors [Bai et al., 2007]. Rheb 
regulates mTOR through FKBP38, which by binding to mTOR inhibits its activity. To 
prevent this association, Rheb interacts directly with FKBP38. In different words, 
FKBP38 is an inhibitor of mTOR, which in response to growth factor and nutrients 
conditions is antagonized by Rheb [Bai et al., 2007].                                                                             
mTOR controls the level of phosphorylation of Atg13, one of the proteins involved in 
induction of autophagy pathway. Under nutrient – rich conditions, during the normal 
cell life, Atg13 occurs in highly phosphorylated form, which has low affinity for Atg1 
kinase – another autophagy related protein, essential for induction of autophagy. In this 
case autophagy is suppressed [T. Yorimitsu, 2005]. Inhibition of mTOR results on 
dephosphorylation of Atg13, which in this form has higher affinity for Atg1. New 
created Atg1-Atg13 complex allows to switch from basal Cvt pathway (basal 
autophagy) to induced autophagy. 
Reactions, which visualise mTOR activation/deactivation and autophagy 
induction, are based on diagram above: 
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Table 4.1 Reactions involved in autophagy induction. 
Reaction Reference 
1
1 :
TCTP
AA B
kGDP GTPR Rheb GTP Rheb GDP
+
↓+ → +  
Bai & Jiang, 2009; Bai et al., 2007; 
Roccio et al., 2006; Avruch et al., 
2006; Kim, 2009; 
2
2 :
TSC
kGTP GDP
iR Rheb Rheb P↓→ +  
Bai & Jiang, 2009; Bai et al., 2007; 
Kim, 2009; Zhang et al., 2003 
3
3
3 : ( _ 38)
( _ 38)
kGTP
k GTP
R Rheb mTOR FKBP
Rheb FKBP mTOR
+ ←→
←→ +
 
Bai & Jiang, 2009; Bai et al., 2007; 
Kim, 2009; Sato et al., 2009; Wang et 
al., 2008 
4
4 : 13 ( 13_ )
mTOR
kR Atg ATP Atg P ADP↓+ → +  
Kamada et al., 2000; Kamada et al., 
2010; Klionsky and Emr, 2000; 
?
5
5 : ( 13_ ) 13
k
iR Atg P Atg P↓→ +  
Kamada et al., 2000; Kamada et al., 
2010; Hosokawa et al., 2009; 
Klionsky and Emr, 2000; 
6
6 : 13 1 ( 1_ 13)kR Atg Atg Atg Atg+ ←→  Kamada et al., 2000; Hosokawa et 
al., 2009; Klionsky and Emr, 2000; 
7
7 : ( 1_ 13) 1 13
mTOR
kR Atg Atg Atg Atg↓→ +  
Kamada et al., 2000;  
 
The rate expressions for reactions above are: 
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mTORAtgAtgk
AtgAtgk
AtgAtgk
PAtgk
mTORAtgk
mTORFKBPRhebk
FKBPmTORRhebk
Rhebk
BAARhebk
GTP
GTP
GDP
GDP
⋅⋅=
⋅=
⋅⋅=
⋅=
⋅⋅=
⋅⋅=
⋅⋅=
⋅=
+⋅⋅=
−−
−−
)13_1(
)13_1(
113
_)_13(
13
)38_(
)38_(
)(
77
661
66
55
44
33
33
22
11
υ
υ
υ
υ
υ
υ
υ
υ
υ
                                                                    
In the rate expressions some substrates are missing on purpose. If we assume 
that values of TSC and TSTP are constant, we do not have to take them into calculations 
(reaction R1 and R2). It is sufficient if the speed of the reaction R1 is driven only by 
amino acids. Also to simplify our model initially we assume that energy equivalents 
such as GTP are not limited, therefore we can leave GTP, Pi and ATP out of the 
calculations (reaction R1 and R4). An unknown phosphatase takes part in reactionR5, 
Atg13 dephosphorylation [Klionsky and Emr, 2000; Kamada et al., 2000]. With 
assumption that the amount of phosphatase does not change we do not include it into 
equations.  
Based on reaction above we can describe the temporal change in concentration 
of the proteins and the complex by using an ordinary differential equation:  
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1 2
1 2
3 3
3 3
( ) [ ]
( ) [ ]
( _ 38) ( _ 38)
( _ 38) ( _ 38) ( _
GDP
GDP GTP
GTP
GDP GTP
GTP GTP
GTP
GTP GTP
d Rheb k Rheb AA B k Rheb
dt
d Rheb k Rheb AA B k Rheb
dt
k Rheb mTOR FKBP k mTOR Rheb FKBP
d Rheb FKBP k Rheb mTOR FKBP k mTOR Rheb FK
dt
−
−
= − ⋅ ⋅ + + ⋅
= ⋅ ⋅ + − ⋅ −
− ⋅ ⋅ + ⋅ ⋅
= ⋅ ⋅ − ⋅ ⋅
3 3
3 3
4 5 6 6
38)
( _ 38) ( _ 38) ( _ 38)
( ) ( _ 38) ( _ 38)
( 13) 13 ( 13_ ) 13 1 ( 1_ 1
GTP GTP
GTP GTP
BP
d mTOR FKBP k Rheb mTOR FKBP k mTOR Rheb FKBP
dt
d mTOR k Rheb mTOR FKBP k mTOR Rheb FKBP
dt
d Atg k Atg mTOR k Atg P k Atg Atg k Atg Atg
dt
−
−
−
= − ⋅ ⋅ + ⋅ ⋅
= ⋅ ⋅ − ⋅ ⋅
= − ⋅ ⋅ + ⋅ − ⋅ ⋅ + ⋅
4 5 7
6 6
6 6 7
3)
( 13_ ) 13 ( 13_ ) ( 1_ 13)
( 1_ 13) 13 1 ( 1_ 13)
( 1) 13 1 ( 1_ 13) ( 1_ 13)
d Atg P k Atg mTOR k Atg P k Atg Atg mTOR
dt
d Atg Atg k Atg Atg k Atg Atg
dt
d Atg k Atg Atg k Atg Atg k Atg Atg mTOR
dt
−
−
= ⋅ ⋅ − ⋅ + ⋅ ⋅
= ⋅ ⋅ − ⋅
= − ⋅ ⋅ + ⋅ + ⋅ ⋅
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This section with details describes model parameterization and implementation, 
and gives an explanation of methods which were used to obtain set of parameters. Our 
mathematical model is calibrated using published experimental data on the autophagy 
pathway in mammalian cells. 
 
4.1.1 Parameterization of kinetic constants k1 and k2 
Parameters k1 and k2 for the first pair of reactions (figure 4.1.1) were derived 
from the two publications by Inoki et al and Marshall et al [Inoki et al., 2003 and 
Marshall et al., 2009].   
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Figure 4.1.1 represents the first reactions which are implemented in our model. 
The activity of Rheb, which is a small GTPase, depends on its nucleotide-binding state, 
which is controlled by a GTPase-activating protein (GAP) and a guanine nucleotide 
exchange factor (GEF). The GAP for Rheb is the TSC1/TSC2 complex, which 
stimulates GTP hydrolysis. Recently, TCTP has been suggested to be the GEF for Rheb 
[Bai and Jiang, 2009]. 
 
                         
Figure 4.1.1 Cycling of Rheb GTPase protein between the active and inactive forms. 
Conversion of the active RhebGTP into the inactive RhebGDP form by hydrolysis of GTP 
is catalyzed by TSC (GAP for Rheb). The reverse reaction is promoted by TCTP (GEF 
for Rheb) [references: Bai & Jiang, 2009; Bai et al., 2007; Roccio et al., 2006; Avruch 
et al., 2006; Kim, 2009; Zhang et al., 2003]. 
 
As was mentioned in the previous chapter, we can assume that the amounts of 
TSC and TSTP are constant, so here we do not need to consider them in the 
calculations. Also to simplify our model, initially we assume that energy equivalents 
   k2 
Pi 
TSC 
k1 
RhebGDP RhebGTP 
   
TCTP 
      GTP            GDP 
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such as GTP are not limited. Therefore we can leave GTP, GDP and Pi out of the 
calculations.  
 
Simplified rate expressions extracted from the figure 4.1.1: 
GTP
GDP
Rhebk
Rhebk
⋅=
⋅=
22
11
υ
υ
 
 
4.1.1.1 Parameter k2  
Inoki et al. showed that the TSC1/TSC2 complex stimulates the GTP hydrolysis 
of Rheb. In figure 1C from that publication the authors displayed the time-dependent 
GTP hydrolysis of Rheb stimulated by TSC, as measured by radioactive counting of 
free 32P-phosphate, which is released during hydrolysis. From the experimental data 
shown we quantified that after 30 minutes the relative activity of free 32P-phosphate 
slowly approached saturation. Based on that partial set of data we extrapolated that in 
the presence of TSC almost all (95%) RhebGTP is converted into RhebGDP within 60 
minutes with a kinetic closely resembling an exponential decay (figure 4.1.2).  
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Figure 4.1.2 Representation of the RhebGTP hydrolysis. The plot represents the curve 
of the exponential decay for the RhebGTP hydrolysis in the presence of TSC, which 
catalyses this reaction. The time of 95% completion of GTP hydrolysis was derived 
from experimental data from Inoki et al., 2003 and used to plot the exponential decay 
curve. 
 
The curve equation for the exponential decay is: 
                                                         
tk
eyy ⋅−⋅= 20                                                     (4.1.1) 
where y is a quantity at time t , 0y  is an initial amount of Rheb
GTP
, and 2k  indicates the 
decay constant. From (4.1.1) and the assumption that at time 60=t min only 5% of 
RhebGTP is left, the decay rate is: 
                                            04992.005.0ln2 =
−
=
t
k  min-1                                       (4.1.2) 
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The half time of the RhebGTP hydrolysis thus calculated as 
                                                      142ln
22
1 ≅= k
t  min                                             (4.1.3) 
 
During the course of this study another paper was published, which we could 
use for our model parameterization [Marshall et al., 2009]. The authors explored the 
molecular mechanism of the RhebGTP hydrolysis alone or in the presence of TSC. 
Experiments were based on a real-time assay, which took advantage of nuclear 
magnetic resonance (NMR) spectroscopy. According to their results, “addition of TSC 
to GTP-bound Rheb at a 1:2 molar ratio increased Rheb’s rate of GTP hydrolysis by 50-
fold (compared to the experiment of GTP hydrolysis in absence of TSC) to 
1min031.0 −=k ” [Marshall et al., 2009]. The time of 95% RhebGTP hydrolysis based on 
this rate constant calculates as 100 minutes, with a corresponding half time of the 
reaction min7.21
2
1 =t . While this is slightly longer than the half time determined from 
Inoki et al., it still displays a good match between independent studies. We therefore 
decided to calculate the average value of 2k  from these two publications, which is: 
04046.02 =k  min
-1 
The average half time of the RhebGTP hydrolysis is: 
17
2
1 ≅t  min. 
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Using the model in absence of all reactions except for R2 we could show that k2 
corresponded to published data. The plot below shows the hydrolysis of RhebGTP in the 
presence of TSC: 
 
 
Figure 4.1.3 Result of the simulation for reaction 2R  with decay constant 
04046.02 =k  min
-1
. The plot was made as a result of a simulation in SBtoolbox for 
MatLab and shows the exponential decay of RhebGTP by TSC catalysed hydrolysis. The 
half time for this reaction is 17≅ minutes, corresponding well with published data. 
 
 
4.1.1.2 Parameter k1  
To calculate the parameter 1k  for our model, we focused again on Inoki et al. 
Experimental data from this paper indicated that the ratio of GTP/GDP- bound Rheb in 
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living cells comes to 66.1=GDP
GTP
Rheb
Rheb
. The ratio is formulated in the steady state 
condition, that is: 
                                               0==
dt
dRheb
dt
dRheb GDPGTP
                                       (4.1.4) 
 
From the ordinary differential equations, which describes change in 
concentrations of the proteins, where GTPGDP
GDP
RhebkRhebk
dt
dRheb
⋅+⋅−= 21  and 
GTPGDP
GTP
RhebkRhebk
dt
dRheb
⋅−⋅= 21 , the ratio is equivalent to: 
                                                      
2
1
k
k
Rheb
Rheb
GDP
GTP
=                                                    (4.1.5) 
From this we calculated 1k  by 
                                                    GDP
GTP
Rheb
Rhebkk 21 =                                                    (4.1.6) 
 
According to the equation above, parameter 1k  for our model comes to 
06716.01 =k  min
-1
 
The half time for the TCTP catalysed conversion of RhebGDP into RhebGTP calculates as: 
10
2
1 ≅t  min. 
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Using the model in absence of all reactions except for R1 a similar simulation as 
before was made to check the correct software implementation of the parameter k1, 
which drives reverse reaction to RhebGTP hydrolysis, converting RhebGDP to RhebGTP: 
 
 
Figure 4.1.4 Result of the simulation for reaction 1R  with decay constant for RhebGDP 
06716.01 =k  min
-1
. The plot was made by a simulation in SBtoolbox for MatLab and 
shows the exponential decay of RhebGDP by conversion into RhebGTP. The half time for 
this reaction is 10≅ minutes, which corresponds well with calculated half time above). 
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4.1.1.3 Model testing for parameters k1 and k2 
Using SBtoolbox, the rate expressions based on figure 4.1.1 and parameters k1 
and k2 obtained as above, we tested the model for the two first reactions, which 
represents turnover of RhebGTP into RhebGDP and vice versa. The simulations conducted 
show two different initial conditions: a) when 100)0( =GTPRheb  and 0)0( =GDPRheb ; 
b) when 0)0( =GTPRheb  and 100)0( =GDPRheb . The first condition represents 
oversaturated nutrient conditions, when all Rheb is in an active GTP-bound form. The 
second condition mimics nutrients starvation, when all RhebGTP is converted to the 
inactive form. These two scenarios thus show opposite extreme conditions. 
In the first scenario we expect that RhebGTP levels should decrease, because a 
part of it is converted to RhebGDP. On the other hand, the level of RhebGDP should 
increase. Ultimately, a steady state ratio GDP
GTP
Rheb
Rheb
 of 1.66 was expected to be achieved. 
In the second condition we expected that RhebGTP levels increase because of 
conversion of RhebGDP into RhebGTP. In this scenario also the experimentally 
determined steady state ratio of 1.66 should be reached. 
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Figure 4.1.5a Result of the simulation for reactions 1R  and 2R  when 
100)0( =GTPRheb  and 0)0( =GDPRheb . A ratio 63.1=r  of 
GTP
GDP
Rheb
Rheb
 is reached after 
100 minutes, closely approaching the steady state of 1.66. 
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Figure 4.1.5b Result of the simulation for reactions 1R  and 2R  when 0)0( =GTPRheb  
and 100)0( =GDPRheb . A ratio 63.1=r  of 
GTP
GDP
Rheb
Rheb
 is reached after 100 minutes, 
closely approaching the steady state of 1.66. 
 
 
 
In both plots (4.1.5a and 4.1.5b) we can see that the value of the ratio of GTP/GDP- 
bound Rheb after 100 minutes is 63.1=GDP
GTP
Rheb
Rheb
. We also made simulations for the 
same conditions for a time 1000 minutes (figure not shown). We could observe that the 
final levels of RhebGTP and RhebGDP were slightly different than this one after 100 
minutes. They reached 62.5% and 37.5% respectively, which gives a ratio 1.66. 
 We therefore conclude that we successfully implemented this pair of reactions 
and can re-model the published biological behaviour of the reactions 1R  and 2R . 
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4.1.2 Parameterization of kinetic constants k3 and k-3 
Parameters k3 and k-3 for the second pair of reactions (figure 4.1.6) were derived 
from the two publications by Bai et al and Sato et al [Bai et al., 2007 and Sato  et al., 
2009].   
Figure 4.1.6 represents the following reactions which are implemented in our 
model. FKBP38, by direct binding to mTOR, inhibits the activity of mTORC1 [Bai and 
Jiang, 2009; Bai et al., 2007]. The interaction of FKBP38 with mTOR is controlled by 
Rheb in the GTP-dependent manner [Bai and Jiang, 2009]. RhebGTP inhibits this 
association by competitively binding to FKBP38 [Bai et al., 2007], and in turn results in 
activation of mTOR. 
 
Figure 4.1.6 Reaction of RhebGTP-dependent mTOR activation and FKBP38-
dependent mTOR inhibition. Rheb in the active GTP-bound form binds to FKBP38 and 
leads to mTOR activation. In the reverse reaction mTOR is inhibited by FKBP38 
through direct binding [references for that reactions: Bai & Jiang, 2009; Bai et al., 
2007; Kim, 2009; Sato et al., 2009; Wang et al., 2008]. 
 
Rate expressions extracted from the figure 4.1.6: 
)38_(33 FKBPmTORRhebk GTP ⋅⋅=υ  
RhebGTP RhebGTP_FKBP38     k3 
   k
-3 
mTOR_FKBP38 
mTOR 
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mTORFKBPRhebk GTP ⋅⋅=
−−
)38_(33υ  
 
4.1.2.1 Parameter k3  
 Sato and colleagues experimentally showed that RhebGTP activates mTOR [Sato 
et al., 2009]. Cells were first starved to shut down mTOR activity. In starvation mTOR 
binds to its endogenous inhibitor FKBP38. The kinase activity was measured by 
measuring phosphorylation of the mTOR substrate 4E-BP1. The phosphorylation of 4E-
BP1 during the starvation period is minimal, but the addition of RhebGTP enhanced the 
mTOR kinase activity substantially (figure 4.1.7). 
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Figure 4.1.7 mTOR activation by RhebGTP. Activation of mTOR is measured as an 
intensity of the phosphorylation of 4E-BP1. Figure shows results in starvation (red 
squares) and after addition of RhebGTP (dark blue squares). Plot based on figure 1C, 
page 12785 from Sato et al., 2009, modified and plotted in Microsoft Office Excel 2003. 
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As we can see, after addition of active Rheb to the starving cells, full activation 
of mTOR occurs in 20 minutes (figure 4.1.7). According to the figure above and the 
figure 4.1.6, we therefore can say that time to achieve completion of reaction 3R  is 
approximately 20 minutes. Based on all this information we can assume that after 
addition of Rheb, amount of an inactive mTOR-FKBP38 complex decrease with the 
same kinetics as mTOR activity increases (figure 4.1.8). 
 
Level of the mTOR-FKBP38 (inactive complex) 
in the time of Rheb-GTP incubation
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Figure 4.1.8 Decrease of the mTOR_FKBP38 complex after addition of RhebGTP to 
the starving cells. The equation of the exponential decay, with the decay constant 
2259.03 =k  min
-1
, was given after adding the best suited trend line in Microsoft Office 
Excel 2003. Plot made based on figure 5.6 and Bai et al., 2007. 
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The half time of the mTOR-FKBP38 complex decreasing  
                                                         32ln
32
1 ≅= k
t  min                                           (4.1.7)              
which also can be observe from the figure 4.1.8.    
 
As we can see from the rate expression, which is based on the figure 4.1.6, 
)38_(33 FKBPmTORRhebk GTP ⋅⋅=υ , reaction R3 is dependent on RhebGTP. Both 
mTOR_FKBP38 complex and RhebGTP are reactants consumed in reaction R3. These 
reactions are different to the reactions in the previous chapter; here we have two 
reactants and we can say that they have a nature of second-order process, in which the 
concentrations of the two reactants behave the same.  
For a second-order reactions the half time is depended on the initial value of the 
reactant A: 
                                             ][
1
02
1 Ak
t
⋅
=                                                     (4.1.8) 
 
Base on above equation we could calculate the rate constant for reaction R3, which is: 
                                            3
1
2
1
[ _ 38]k t mTOR FKBP= ⋅                                        (4.1.9) 
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and assuming, that the initial value for the complex is _ 38(0) 100mTOR FKBP = rate 
constant comes then to 113 min00333.0
−−
⋅= uk , where u represents relative unit, in our 
model [%]. 
Using the model in absence of all reactions except for R3 we could show that k3 
could reproduce the published data. The plot below shows the exponential decay of 
mTOR_FKBP38 complex after addition of active RhebGTP. 
 
 
Figure 4.1.9 Result of the simulation for reaction 3R  with decay constant for 
mTOR_FKBP38 decreasing 113 min00333.0 −− ⋅= uk . The plot was made as a result of 
simulation in SBtoolbox for MatLab and shows the exponential decay of 
mTOR_FKBP38 in the reaction of mTOR activation. The half time for this reaction is 
3≅ minutes, corresponding well with published data. (u represents relative unit, %). 
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4.1.2.2 Parameter k
-3  
To derive parameter k
-3 for the reverse reaction, inhibition of mTOR activity by 
FKBP38, we have studied publication by Bai et al., where they describe inhibition of 
mTOR kinase activity by FKBP38. 
In their experiment, the inhibitory effect of FKBP38 on mTOR activity was 
tested. From the material and methods chapter we know that to determine the effect of 
FKBP38 on the kinase activity, 2 µg of FKBP38 was used and incubated with the cells 
for 10 minutes. After the time of incubation mTOR activity was decreased to 40% of 
the initial value (figure 4.1.10). 
 
Inhibition of mTOR activity by FKBP38
0
20
40
60
80
100
0 10
Time [min]
R
el
at
iv
e 
in
te
n
si
ty
 
o
f 
ph
o
sp
ho
-
4E
-
B
P1
 
Figure 4.1.10 Effect of FKBP38 on the mTOR kinase activity. After 10 minutes of 
incubation with 2 µg of FKBP38, the activity of mTOR dropped to 40% of initial 
activity. Figure based on data from Bai et al., 2007 and figure 2D from this publication. 
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Since the mTOR_FKBP38 complex decreases in exponential decay manner after 
addition of Rheb ( 3k  parameterization), we can assume that mTOR activation, as a 
reverse reaction, proceeds with similar characteristic. Based on that the curve equation 
for the exponential decay of mTOR activity is: 
                                                       
tk
eyy ⋅− −⋅= 30                                                    (4.1.10) 
at time 10=t  min the value of 4.0=y  is achieved. The kinetic rate therefore is: 
                                       09163.04.0ln3 =
−
=
− t
k  min-1                                                                (4.1.11) 
and a half time for the inhibition: 
                                                    5.72ln
32
1 ≅=
−
k
t  min                                           (4.1.12) 
According to the method which was used above ( 3k  parameterization) we can calculate 
the rate constant for the reaction R
-3. Here again we have two reactants, mTOR and 
RhebGTP_FKBP38, both of which are consumed in the reaction. We can say that they 
have a nature of second-order process. With the assumption that the initial value for 
mTOR is 100)0( =mTOR , we can use equation (4.1.9) to derived k
-3, which comes then 
to 113 min00133.0
−−
−
⋅= uk . 
Using the model in absence of all reactions except for R
-3 we could show that 
the calculated k
-3 matches published data. The plot below shows exponential decay of 
mTOR-FKBP38 complex after addition of active RhebGTP. 
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Figure 4.1.11 Result of the simulation for reaction R
-3 with decay constant for mTOR 
decreasing 113 min09163.0 −−− ⋅= uk . The plot was made as a result of simulation in 
SBtoolbox for MatLab and shows the exponential decay of mTOR8 in the reaction of 
mTOR inhibition by FKBP38. The half time for this reaction is 5.7≅ minutes, 
corresponding well with published data. 
 
4.1.2.3 Model testing for parameters k3 and k-3 
Using SBtoolbox, the rate expressions based on figure 4.1.6 and parameters 3k  
and 3−k  obtained as above, we tested the model for two reactions, which represent 
activation of mTOR by RhebGTP and mTOR inhibition by FKBP38, respectively. The 
simulations show two different initial conditions: a) when 100)0( =GTPRheb   and 
0)0( =mTOR  ( 100)0(38_ =FKBPmTOR  and 0)0(38_ =FKBPRhebGTP ); b) when 
0)0( =GTPRheb  and 100)0( =mTOR  ( 0)0(38_ =FKBPmTOR  and 
100)0(38_ =FKBPRhebGTP ).  
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The first condition represents oversaturated nutrient conditions, when all Rheb is 
in an active GTP form. In this scenario we expected that the level of RhebGTP should 
decrease, because it is converted to the complex with FKBP38. Activity of mTOR 
should rapidly increase, because RhebGTP, which is necessary for this activation, is 
already in a full GTP state. In turn, the level of inactive complex mTOR-FKBP38 
should rapidly decrease, as a reverse reaction to mTOR activation. Also the 
RhebGTP_FKBP38 complex was supposed to increase with mTOR activation. 
 
 
Figure 4.1.12a Result of the simulation for reactions R3 and R-3 when 
100)0( =GTPRheb  and 0)0( =mTOR . With the increasing activation of mTOR, the level 
of the RhebGTP decreases, since it is used for this activation. 
 
The second condition mimicked nutrient starvation, when all RhebGTP is 
converted to the inactive form, but mTOR remains present in an active form. In this 
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scenario we expect that the level of RhebGTP should increase, because it is released from 
the complex RhebGTP_FKBP38 in the reaction R
-3. The activity of mTOR should 
decrease, because RhebGTP_FKBP38 complex which is necessary for its inhibition is 
present in the system. In turn, the level of inactive complex mTOR_FKBP38 should 
increase, as a consequence of the mTOR inhibition. Also the RhebGTP_FKBP38 
complex was expected to decrease as long with mTOR activation.  
 
Figure 4.1.12b Result of the simulation for reactions R3 and R-3 when 0)0( =GTPRheb  
and 100)0( =mTOR . Because of inhibition by FKBP38, mTOR decreases. At the same 
time, RhebGTP increases, since it is a product of this inhibition. 
 
In both plots (figure 4.1.12a and 4.1.12b) we observe that the final steady state 
values of the all products are the same respectively in both conditions, and they come to 
~62% for mTOR and RhebGTP-FKBP38 and to ~38% for RhebGTP and mTOR-FKBP38. 
To compare parameters 33 / −kk  with 21 / kk  we can see that reactions 3R  and 3−R  are 
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faster and they approached steady state after approximately 15 minutes (compare to 
reactions 1R  and 2R  approximately 60 minutes). 
We showed here results of the simulations with the simplified condition of 
nutrient saturation. The majority of mTOR is in its active state (62%) which correlates 
with the biological experimental data. 
 
4.1.3 Parameterization of kinetic constants k4 and k5 
Parameters 4k  and 5k  for the reactions R4 and R5 (figure 4.1.13) were derived 
from the publication by Kamada et al [Kamada et al., 2000].   
Figure 4.1.13 represents the reactions R4 and R5 which are implemented in our 
model. Under nutrient rich conditions, and when the cell is in a normal living state, 
active mTOR keeps Atg13 in a hyperphosphorylated state, that is, almost all Atg13 is 
phosphorylated to Atg13_P. During cell starvation mTOR is inhibited and this results in 
dephosphorylation of Atg13_P. 
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Figure 4.1.13 mTOR controls the level of phosphorylation of Atg13. Under nutrient 
rich conditions, almost all Atg13 is phosphorylated to the form Atg13_P. Inhibition of 
mTOR, which occurs during starvation, results in Atg13 dephosphorylation [references 
for the reactions: Kamada et al., 2000; Kamada et al., 2010; Hosokawa et al., 2009; 
Klionsky and Emr, 2000]. 
 
Simplified rate expressions extracted from the figure 4.1.13: 
 
4 4
5 5
13
( 13_ )
k Atg mTOR
k Atg P
υ
υ
= ⋅ ⋅
= ⋅
 
 
In these rate expressions, for simplicity we have deliberately suppressed the 
influence of other substrates. We initially assume that energy equivalents such as ATP 
are not limited; therefore we can leave ATP, ADP and Pi out of the calculations. An 
unknown phosphatase that takes part in reaction R5, Atg13 dephosphorylation [Klionsky 
and Emr, 2000; Kamada et al., 2000] is assumed to have a constant influence on the 
   k4 
      k5 
Atg13 Atg13_P    
Pi 
    ATP            ADP 
mTOR 
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reaction rate. Therefore, any dependence on this phosphatase is absorbed into the 
constant k5.  
 
4.1.3.1 Parameter k5  
Kamada and colleagues experimentally investigated the biochemical character of 
Atg13 [Kamada et al., 2000]. They observed that in growing cells Atg13 occurs in the 
phosphorylated form, and after starvation or mTOR inhibition by rapamycin this form 
disappeared (dephosphorylation). In starvation condition Atg13 dephosphorylation 
takes 30 minutes, whereas after rapamycin treatment only 5 minutes (figure 3A from the 
Kamada et al., 2000). This difference in reaction rates stems from the fact that 
rapamycin acts direct on mTOR by blocking its activity, whereas the signal from amino 
acids deprivation first results in the transformation of RhebGTP to RhebGDP, and then 
Rheb in this inactive form mediates inhibition of mTOR (figure 4.1).  
For our calculations we used the data from the rapamycin treatment, because we 
were interested in the immediate effects of mTOR inhibition on Atg13 
dephosphorylation. Within 5 minutes after rapamycin treatment Atg13 was 
dephosphorylated. The same publication, based on the experiment suggested, that 
“Atg13 remains partially phosphorylated under starvation conditions” [Kamada et al., 
2000]. We therefore assumed that after 5 minutes after rapamycin treatment 95% of 
Atg13 was transformed into the unphosphorylated form (figure 4.1.14). 
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Figure 4.1.14 Representation of the Atg13-P dephosphorylation. The plot represents 
the curve of the exponential decay for the Atg13-P dephosphorylation after rapamycin 
treatment. The time of 95% completion of Atg13-P dephosphorylation was derived from 
experimental data from Kamada et al., 2000 and used to plot the exponential decay 
curve. 
 
The curve equation for the exponential decay is: 
                                                         
tk
eyy ⋅−⋅= 50                                                   (4.1.13) 
where y is a quantity at time t , 0y  is an initial amount of Atg13_P, and 5k  indicates the 
decay constant. From (4.1.13) and the assumption that at time 5=t min only 5% of 
Atg13_P is left, the decay rate is: 
                                            5991.005.0ln5 =
−
=
t
k  min-1                                       (4.1.14) 
The half time of the Atg13_P dephosphorylation thus calculated as 
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                                                 15.12ln
52
1 ≅= k
t  min                                             (4.1.15) 
Using the model in absence of all reactions except for 5R  we could show that 5k  
corresponded to published data. The plot below shows the dephosphorylation of Atg13-
P after rapamycin treatment (4.1.15): 
 
 
Figure 4.1.15 Result of the simulation for reaction 5R  with decay constant 
5991.05 =k  min
-1
. The plot was made as a result of a simulation in SBtoolbox for 
MatLab and shows the exponential decay of Atg13-P after treatment with rapamycin. 
The half time for this reaction is 15.1≅ minutes, which corresponds well with published 
data.  
 
4.1.3.2 Parameter k4  
In the next experiment Kamada and colleagues were again testing the sensitivity 
of the phosphorylation state of Atg13 [Kamada et al., 2000]. They found that after re-
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addition of growth medium to the starved cells, the dephosporylated form of Atg13 was 
phosphorylated within 10 minutes (figure 3D from the Kamada et al., 2000). This 
means, according to the diagram of the biochemical reaction involved in the autophagy 
pathway (figure 4.1), that reactions R1, R3 and R4 together take 10 minutes. But from 
the previous calculations, which were based on experimental publications, we already 
know the half times for the reaction R1, which is 10 minutes, and for the reaction R3, 
which is 3 minutes. We can assume that all three reactions take 15 minutes (which is 
still in the correct range, compare to 10 minutes from Kamada, et al, 2000) and thereby, 
reaction R4 is estimated to take 2 minutes. 
Based on this information we know that after re-addition of the growth medium, 
due to phosphorylation, amount of Atg13 decrease (figure 4.1.16). 
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Figure 4.1.16 Representation of Atg13 phosphorylation. The plot represents the curve 
of the exponential decay for the Atg13 due to phosphorylation after re-addition the 
growth medium to the staved cells. The data of Atg13 phosphorylation was derived from 
experimental data from Kamada et al., 2000 and used to plot the exponential decay 
curve. 
 
According to the equations (4.1.13) and (4.1.14) the decay rate for Atg13 during 
phosphorylation is 4979.105.0ln4 =
−
=
t
k  min-1 and the corresponding half time 
calculated as in (4.1.15) comes to 46.02ln
42
1 ≅= k
t  min-1. 
As we can see from the reaction rate mTORAtgk ⋅⋅= 1344υ , which is based on 
figure 4.1.13, reaction of Atg13 phosphorylation is dependent on mTOR (k4 includes 
already influence from mTOR). In reaction R4 mTOR acts as an enzyme, which 
catalyses this reaction and increases the reaction rate. To derive the exact rate constant 
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for reaction R4, we have to divide it by the concentration of the enzyme (mTOR). This 
leads to the value of constant 114 min01498.0 −− ⋅= uk , where u represents relative unit, 
%. 
Using the model in absence of all reactions except for 4R  and implementing 
mTOR as a constant value ( 100)0( =mTOR  and 0)( =
dt
mTORd ) together with the value 
of  k4 above, we can reproduce the published data. The plot below shows the 
exponential decay of Atg13 after re-addition of amino acids to the starved cells (figure 
4.1.17). 
 
 
Figure 4.1.17 Result of the simulation for reaction 4R  with decay constant 
11
4 min01498.0 −− ⋅= uk . The plot was made as a result of a simulation in SBtoolbox for 
MatLab and shows the exponential decay of Atg13 after re-addition of the growth 
medium to the starved cells. The half time for this reaction is 46.0≅ minutes, 
corresponding well with published data. 
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4.1.3.3 Model testing for parameters k4 and k5 
Using SBtoolbox, rate expressions based on figure 4.1.13 and parameters 4k  
and 5k  obtained above, we tested the model for the reactions R4  and R5, which 
represents turnover of Atg13 into the phosphorylated form Atg13-P and vice versa. The 
simulations conducted show two different initial conditions: a) when 
100)0(_13 =PAtg  and 0)0(13 =Atg ; b) when 0)0(_13 =PAtg  and 100)0(13 =Atg . 
The first condition represents oversaturated nutrient conditions, when all Atg13 is in a 
phosphorylated form. The second condition mimics nutrients starvation, when all Atg13 
is converted to the unphosphorylated form. These two scenarios thus show opposite 
extreme conditions. 
In the first scenario we expect that Atg13-P levels should decrease, because a 
part of it is converted to Atg13. On the other hand, the level of Atg13 should increase. 
In the second condition we expected that Atg13 levels decrease because a part of it is 
converted to phosphorylated Atg13-P form. In both scenarios Atg13-P should reached 
higher level in the steady state conditions. 
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Figure 4.1.18a Result of the simulation for reactions 4R  and 5R  when 
100)0(_13 =PAtg  and 0)0(13 =Atg . With the decreasing in the phosphorylated form 
of Atg13, the level of the unphosphorylated Atg13 increases. 
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Figure 4.1.18b Result of the simulation for reactions 4R  and 5R  when 
0)0(_13 =PAtg  and 100)0(13 =Atg . With the decrease in the unphosphorylated form 
of Atg13, the level of the phosphorylated Atg13_P increases. 
 
On both plots (figure 4.1.18a and 4.1.18b) we can observe that final steady states 
values of the products are the same respectively in both conditions, and they come to 
~72% for Atg13-P and to ~28% for Atg13.  
 
4.1.4 Parameterization of kinetic constants k6, k-6 and k7 
Figure 4.1.19 represents the next reactions which are implemented in our model. 
Parameters k6, k-6 and k7 for the next reactions were derived from the publication by 
Kamada et al [Kamada et al., 2000].   
Under nutrient rich conditions, during the normal cellular life, active mTOR 
keeps Atg13 in hyperphosphorylated state (reaction R4). In starvation mTOR is 
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inhibited and this results in Atg13 dephosphorylation (reaction R5). Dephosphorylated 
Atg13 has a high affinity to Atg1, and together they create a complex (reaction R6). 
Atg1_Atg13 complex spontaneously break up in reverse reaction (reaction R
-6), and 
also after re-activation of mTOR (reaction R7).  
 
       
Figure 4.1.19 The level of phosphorylation of Atg13 controlled by mTOR and 
Atg1_Atg13 complex formation. Under nutrient rich conditions Atg13 occurs in the 
highly phosphorylated form (reaction 4). Inhibition of mTOR, for example during cell 
starvation, results in Atg13 dephosphorylation (reaction 5) and Atg1_Atg13 complex 
formation (reaction 6). This complex can break up in the reverse reaction (reaction -6) 
and after mTOR re-activation (reaction 7) [references for the reactions: Kamada et al., 
2000; Kamada et al., 2010; Hosokawa et al., 2009; Klionsky and Emr, 2000]. 
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Simplified rate expressions extracted from the figure 4.1.19: 
4 4
5 5
13
( 13_ )
k Atg mTOR
k Atg P
υ
υ
= ⋅ ⋅
= ⋅
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In the rate expressions some substrates are again deliberately suppressed. To 
simplify our model initially we assume that energy equivalents such as ATP are not 
limited; therefore we can leave ATP, ADP and Pi out of the calculations. An unknown 
phosphatase participates in reaction 5R , Atg13 dephosphorylation [Klionsky and Emr, 
2000; Kamada et al., 2000]. With assumption that the amount of phosphatase does not 
change we do not include it into equations.  
Kamada et al., 2000 is the only publication that we are aware of, which 
describes the reactions in Atg1_Atg13 complex formation and which gives some 
quantitative information on these reactions. 
 
4.1.4.1 Parameter k7  
Reaction R7 can be treated as a competitive reaction for reaction R4, where in 
both Atg13_P is produced, and both are controlled by mTOR. However, reaction R7 
occurs when Atg1_Atg13 complex is present (so in starvation conditions), while 
reaction R4 occurs always. Reaction R7 is also catalysed by mTOR, therefore we can 
assume that k7 is equal to k4, so 117 min01498.0
−−
⋅= uk , where u represents relative 
unit, %. 
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4.1.4.2 Parameter k6 
From the publication by Kamada et al. we know that after rapamycin treatment 
the formation of the Atg1_Atg13 complex stabilises within about 10 minutes. This 
includes reactions R5 and R6 according to the diagram 4.1.19. As we can see from the 
rate expression, 11366 AtgAtgk ⋅⋅=υ , reaction R6 is dependent on both Atg13 and 
Atg1. Both of them are consumed as reactants in the process of complex formation. We 
can say that they have a nature of second-order process, in which the concentrations of 
the two reactants behave the same.  
Using the model including reactions R4, R5, R6 and R7, and with implemented 
parameters k4, k5 and k7, we tried to find parameter k6. mTOR was implemented as 
model variable, which after 30 minutes was shut off, to mimic rapamycin action. We 
optimized k6 by manual fitting. The goal of the fitting was to find Atg1-Atg13 complex 
increased up to approximately 85% in 10 minutes after rapamycin treatment [Kamada et 
al., 2000]. An optimal value for k6 was found with 0.0066 min-1·u-1, where u represents 
relative unit, %. The result of simulation with the fitted value of k6 is represented on 
figure 4.1.20. 
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Figure 4.1.20 Result of the simulation with the fitted parameter k6. The plot was made 
as a result of a simulation in SBtoolbox for MatLab and shows the behaviour of 
Atg1_Atg13 complex after rapamycin treatment. mTOR was shut off after 30 min as a 
result of rapamycin treatment. In the next 10 min Atg1_Atg13 complex increased to the 
~85% level.  The time 30 min was chosen randomly to ensure that the system was in 
steady state before rapamycin treatment. 
 
In the plot above we can see that in 10 minutes after rapamycin treatment Atg1_Atg13 
complex reached ~85% (from the ~8% in steady state condition in presence of mTOR). 
After mTOR shut off, the level of Atg13 rapidly reached a higher level (due to Atg13_P 
dephosphorylation) and then decreased due to Atg1_Atg13 complex formation. 
 
  
91
4.1.4.3 Parameter k
-6 
Based on the results from the previous simulations we checked how these plots 
changed after addition of reaction R
-6. We expected a slightly lower level of 
Atg1_Atg13 complex in the final steady state condition. 
Reaction R
-6, similar to reaction R7, eliminates the Atg1_Atg13 complex. 
However, in reaction R
-6 parameter k-6 does not depend on mTOR and thus represent a 
spontaneous dissociation reaction.  
Using the model in presence of reaction R4, R5, R6, R-6 and R7, and with 
implemented parameters k4, k5, k6 and k7, we tried to find the parameter k-6 by manual 
fitting. The goal of the fitting was to find a slightly lower level of Atg1-Atg13 complex 
after rapamycin treatment, but behaviour of the rest of the species similar to the 
previous simulation (because there is no a significant influence on the system from 
reaction R
-6). An optimal value for k-6 was found with 0.0059 min-1. Together with the 
rest of the implemented parameters, this combination best represented the changes in 
the individual species. The result of the simulation with the fitted k
-6 is represented on 
figure 4.1.21. 
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Figure 4.1.21 Result of the simulation with the fitted parameter k
-6. The plot was made 
as a result of a simulation in SBtoolbox for MatLab and shows the behaviour of Atg1-
Atg13 complex after rapamycin treatment. mTOR was shut off after 30 min as a result 
of rapamycin treatment. The time 30 min was chosen randomly to ensure that the system 
was in steady state before rapamycin treatment. 
 
In the plot above we can see that in 10 minutes after rapamycin treatment Atg1-Atg13 
complex reached ~83% (from the ~8% in steady state condition in presence of mTOR). 
Level of Atg13 rapidly after mTOR shut off reached a higher level. 
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4.1.4.4 Model testing for parameters k4 – k7 
Using SBtoolbox, rate expressions based on figure 5.18 and parameters k6, k-6 
and k7 obtained as above, we tested the model for the  reactions R4, R5, R6, R-6 and R7. 
The simulations conducted show three different initial conditions (table 4.1.1). 
 
Table 4.1.1 Initial conditions for model testing 
Species 1st initial conditions 2nd initial conditions 3rd initial conditions 
Atg13_P 100 0 0 
Atg13 0 100 0 
Atg1 100 100 0 
Atg1-Atg13 0 0 100 
 
The first condition represents oversaturated nutrient conditions, when all Atg13 
is in a phosphorylated form and there is no Atg1-Atg13 complex. The second condition 
mimics nutrients starvation, when all Atg13 is converted to the unphosphorylated form. 
The third scenario represents also nutrient starvation condition, when all Atg13 and 
Atg1 are converted to the Atg1-Atg13 complex.  
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4.1.4.4.1 Simulations in the normal rich nutrient conditions (in the presence of 
active mTOR) 
We expected that in all three conditions the final steady states for all species will 
be identical. Figure below presents result of the simulation in the first scenario of initial 
conditions (table 4.1.1). 
 
Figure 4.1.22 Result of the model testing for parameters k4-k7 in the normal rich 
nutrient conditions. The plot was made as a result of a simulation in SBtoolbox for 
MatLab and shows the behaviour of Atg1_Atg13 complex, Atg13_P, Atg13 and Atg1 in 
normal nutrient conditions. Initial concentrations for this simulation: Atg13_P(0)=100, 
Atg13(0)=0, Atg1(0)=100 and Atg1_Atg13(0)=0. Steady state of Atg1_Atg13 complex 
is lower than 10%, which is reasonable level in rich nutrient conditions. 
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Figure below presents result of the simulation in the second scenario of initial 
conditions (table 4.1.1). 
 
 
Figure 4.1.23 Result of the model testing for parameters k4-k7 in the normal rich 
nutrient conditions. The plot was made as a result of a simulation in SBtoolbox for 
MatLab and shows the behaviour of Atg1_Atg13 complex, Atg13_P, Atg13 and Atg1 in 
normal nutrient conditions. Initial concentrations for this simulation: Atg13_P(0)=0, 
Atg13(0)=100, Atg1(0)=100 and Atg1_Atg13(0)=0. Steady state of Atg1_Atg13 
complex is lower than 10%, which is reasonable level in nutrient rich conditions. 
 
 
Figure below presents result of the simulation in the third scenario of initial 
conditions (table 4.1.1). 
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Figure 4.1.24 Result of the model testing for parameters k4-k7 in the normal rich 
nutrient conditions. The plot was made as a result of a simulation in SBtoolbox for 
MatLab and shows the behaviour of Atg1_Atg13 complex, Atg13_P, Atg13 and Atg1 in 
normal nutrient conditions. Initial concentrations for this simulation: Atg13_P(0)=0, 
Atg13(0)=0, Atg1(0)=0 and Atg1_Atg13(0)=100. The steady state concentration of 
Atg1_Atg13 complex is less than 10%, which is reasonable level in rich nutrient 
conditions. 
 
In all plots (4.1.22, 4.1.23 and 4.1.24) we can see the levels of each individual 
species reaches the same final level, irrespectively of the initial conditions (table 4.1.1), 
in the normal nutrient conditions (in the presence of active mTOR). Atg1_Atg13 
complex reaches a very low steady states level, on the contrary Atg13_P. Preaches a 
high level. This result is reasonable in the nutrient rich conditions. 
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4.1.4.4.2 Simulations in the inhibition of mTOR 
In the previous simulations (part 4.1.4.4.1) we tested the model in the presence 
of active mTOR. Next we wanted to test the model when mTOR is shut off in the first 
second of simulation, which means that system could not reached the steady state 
before. We expected that when mTOR is inactive the individual species reach different 
steady state levels than in mTOR active - scenario. Thus, we expected that Atg1_Atg13 
complex, which in our model is a marker of autophagy induction, will be in high level 
(due to mTOR inhibition). 
mTOR was implemented as model variable, which after 0.00005 minutes was shut off, 
to mimic rapid rapamycin action. We expected that after inhibition of mTOR in all three 
different conditions (table 4.1.1) final steady states of all species reach the same levels. 
Figure below presents result of the simulation in the first scenario of initial 
conditions (table 4.1.1). 
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Figure 4.1.25 Result of the model testing for parameters k4-k7 in the mTOR 
inhibition. The plot was made as a result of a simulation in SBtoolbox for MatLab and 
shows the behaviour of Atg1_Atg13 complex, Atg13_P, Atg13 and Atg1. Initial 
concentrations for this simulation: Atg13_P(0)=100, Atg13(0)=0, Atg1(0)=100 and 
Atg1_Atg13(0)=0. Steady state of Atg1_Atg13 complex is high ~90%, which is 
reasonable level in the inhibition of mTOR. 
 
Figure below presents result of the simulation in the second scenario of initial 
conditions (table 4.1.1). 
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Figure 4.1.26 Result of the model testing for parameters k4-k7 in the mTOR 
inhibition. The plot was made as a result of a simulation in SBtoolbox for MatLab and 
shows the behaviour of Atg1_Atg13 complex, Atg13_P, Atg13 and Atg1. Initial 
concentrations for this simulation: Atg13_P(0)=0, Atg13(0)=100, Atg1(0)=100 and 
Atg1_Atg13(0)=0. Steady state of Atg1_Atg13 complex is high ~90%, which is 
reasonable level in the inhibition of mTOR. 
 
 
Figure below presents result of the simulation in the third scenario of initial 
conditions (table 4.1.1). 
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Figure 4.1.27 Result of the model testing for parameters k4-k7 in the mTOR 
inhibition. The plot was made as a result of a simulation in SBtoolbox for MatLab and 
shows the behaviour of Atg1-Atg13 complex, Atg13_P, Atg13 and Atg1. Initial 
concentrations for this simulation: Atg13_P(0)=0, Atg13(0)=0, Atg1(0)=0 and 
Atg1_Atg13(0)=100. Steady state of Atg1_Atg13 complex is high ~90%, which is 
reasonable level in the inhibition of mTOR. 
 
In all plots (4.1.25, 4.1.26 and 4.1.27) we can see the levels of all individual 
species reached the same level, respectively to all initial conditions (table 4.1.1), in the 
inhibition of mTOR conditions. Atg1_Atg13 complex reached very high steady states 
level, on the contrary to Atg13_P, which is on the low level. This result is reasonable in 
the mTOR inhibition conditions. 
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4.1.5 Conclusions for model parameterization 
We therefore conclude that we successfully implemented all reactions and can 
re-model the published biological behaviour of the all reactions involved in the 
induction of the autophagy. 
Table 4.1.2 contains all reaction kinetics which are used in the model. 
References for all the calculations and fittings are also enclose.  
 
Table 4.1.2 Reaction kinetics used in the model. 
Rate expression Parameter Value of the 
parameter  
Reference 
 
GTPRhebk ⋅1  
 
k1 
0.06716 
[min-1] 
Calculated based on 
Inoki et al., 2005; 
Marshall et al., 2009 
 
GTPRhebk ⋅2  
 
k2 
0.04046 
[min-1] 
Calculated based on 
Inoki et al., 2005; 
Marshall et al., 2009 
)38_(3 FKBPmTORRhebk GTP ⋅⋅  k3 0.00333 
[min-1·u-1]* 
Calculated based on 
Sato et al., 2009 
mTORFKBPRhebk GTP ⋅⋅
−
)38_(3  k-3 0.00133 
[min-1·u-1] * 
Calculated based on 
Bai et al., 2007 
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mTORAtgk ⋅⋅ 134  k4 0.01498 
[min-1·u-1] * 
Calculated based on 
Kamada et al., 2000 
)_13(5 PAtgk ⋅  k5 0.5991 
[min-1] 
Calculated based on 
Kamada et al., 2000 
1136 AtgAtgk ⋅⋅  k6 0.006649 
[min-1·u-1] * 
Fitting based on 
Kamada et al., 2000 
)13_1(6 AtgAtgk ⋅−  k-6 0.0059 
[min-1] 
Fitting based on  
Kamada et al., 2000 
mTORAtgAtgk ⋅⋅ )13_1(7  k7 0.01498 
[min-1·u-1] * 
Assumption based on 
Kamada et al., 2000 
*
 u represents relative unit, %. 
 
 
In the next part of the thesis we implemented full model with all reactions which 
are involved in the autophagy induction.  
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After extraction all parameters for every single reaction (for details see chapter 
4.1, Model parameterization) we implemented the initial model which includes 
reactions 1 to 7. The input to the system is the initial concentrations of species from the 
first reaction (RhebGDP and RhebGTP), which are not in the ratio of normal nutrient 
conditions. This means that the system needs some time to reach the steady state and 
this time depends on the individual initial concentrations of all species. The output is the 
amount of Atg1-Atg13 complex, which is essential to induce the autophagy pathway.  
 
4.2.1 Simulations and results for initial model without feedback 
The initial conditions of all species for the first 4.2.1A simulation were:  
RhebGDP(0)=100, RhebGTP(0)=0, mTOR(0)=0, mTOR-FKBP(0)=100, RhebGTP-
FKBP(0)=0, Atg13-P(0)=0, Atg13(0)=100, Atg1(0)=100 and Atg1-Atg13(0)=0. These 
initial conditions represent an extreme scenario, where there is no mTOR in the active 
form and all Rheb is in the inactive GDP form. This scenario can mimic starvation 
conditions. Atg13 is in the unphosphorylated form, which allows fast creation of the 
Atg1-Atg13 complex. However, after some time, due to normal regular reactions, the 
system reaches steady states conditions, where the active mTOR concentration is quite 
high and the concentration of the Atg1-Atg13 complex decreases significantly. Figure 
4.2.1 shows the result of simulations with these initial conditions. 
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Figure 4.2.1 Result of simulation 4.2.1A for all reactions involved in autophagy 
induction. The plot displays the results of a simulation using the SBtoolbox for MatLab 
and shows the different behaviours of the individual species for the given initial 
condition. Blue bold line represents Atg1-Atg13 complex, which slowly decreasing with 
mTOR (red) increase. 
 
The steady state for all species is given by: RhebGDP=16.7091, RhebGTP=27.7356, 
mTOR=55.5553, mTOR-FKBP=44.4447, RhebGTP-FKBP=55.5553, Atg13-P=58.1475, 
Atg13=25.1944, Atg1=83.3419 and Atg1-Atg13=16.6581. 
To check the implementation, we run simulation for different initial conditions 
and tested whether the same steady state was reached. The difference in initial 
conditions for the second simulation, compared with the first one, is that all Atg13 is in 
the hyperphosphorylated form, thus Atg13-P(0)=100 and Atg13(0)=0. We expected that 
the Atg1-Atg13 complex would appear later, compared with the simulation 4.2.1A, and 
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that its concentration would be lower, because of the inhibitory role of active mTOR. 
Figure 4.2.2 shows the result of the second simulation. 
 
Figure 4.2.2 Result of the simulation 4.2.1B for all reactions involved in autophagy 
induction. The plot displays the results of a simulation using the SBtoolbox for MatLab 
and shows the different behaviour of the individual species for the given initial 
conditions. Atg1-Atg13 complex (blue) slowly decreases with mTOR (red) increasing. 
Final steady state values of all the species are the same as in previous simulation. 
 
Figure 4.2.3 below shows the result of a third simulation. In this case all Rheb is 
in the active GTP form, thus RhebGDP(0)=0 and RhebGTP(0)=100. This scenario mimics 
rich nutrient conditions, suggesting that the system will reach steady state faster than in 
two previous simulations. The plot 4.2.3 shows the result of this simulation. 
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Figure 4.2.3 Result of the simulation 4.2.1C for all reactions involved in autophagy 
induction. The plot displays the results of a simulation using the SBtoolbox for MatLab 
and shows the different behaviour of the individual species for the given initial 
conditions. mTOR (red) increase very fast, as well as Atg1-Atg13 complex (blue) 
decreases, due to high level of Rheb in an  active GTP form. Final steady state values of 
all the species are the same as in previous simulation. 
 
The initial conditions for the simulation 4.2.1D mimic an extreme starvation 
scenario, when the Atg1-Atg13 complex is in very high concentration, thus Atg13-
P(0)=0, Atg13(0)=0, Atg1(0)=0 and Atg1-Atg13(0)=100.  
While the system is approaching the steady state conditions, the Atg1-Atg13 complex 
should continuously decrease with the increase of mTOR activity. 
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Figure 4.2.4 Result of the simulation 4.2.1D for all reactions involved in autophagy 
induction. The plot displays the results of a simulation using the SBtoolbox for MatLab 
and shows the different behaviour of the individual species for the given initial 
conditions. Atg1-Atg13 complex (blue) decreases slowly from the very high 
concentration, with the slowly increasing of mTOR (red).  Final steady state values of 
all the species are the same as in previous simulation. 
 
In conclusion, our initial model represents the behaviour of all model 
components in response to changes in initial conditions. In all cases, mTOR was not 
inhibited but its initial concentration was always 0. The other species were in conditions 
which might mimic starvation (Rheb in inactive GDP form, Atg13 in unphosphorylated 
form, high level of atg1-Atg13 complex) or in normal nutrient conditions (Rheb in 
active GTP form, Atg13 in hyperphosphorylated form). In all scenarios our system 
reached the same steady state, which is 55.55 % of mTOR and 16.66 % of Atg1-Atg13 
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complex. Table 4.2.1 shows the list of the initial conditions for all simulations and the 
final steady states for all the species. The steady state which was approached is the 
steady state in normal rich nutrient conditions, when all the species function properly. 
The time taken to reach the steady state depended on initial conditions: the closer to 
starvation conditions the longer the time taken to reach steady state. 
 
Table 4.2.1 Initial concentrations for all species involved in the model for the first 
fourth initial simulations 4.2.1A – 4.2.1D 
Species Initial concentrations for simulation 
4.2.1A       4.2.1B     4.2.1C       4.2.1D 
Steady 
state [%] 
RhebGDP 100 100 0 100 16.71 
RhebGTP 0 0 100 0 27.74 
mTOR 0 0 0 0 55.55 
mTOR-FKBP38 100 100 100 100 44.44 
RhebGTP-FKBP38 0 0 0 0 55.55 
Atg13_P 0 100 0 0 58.15 
Atg13 100 0 100 0 25.19 
Atg1 100 100 100 0 83.34 
Atg1-Atg13 0 0 0 100 16.66 
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4.2.2 Implementation of the rapamycin as an mTOR inhibitor 
 In the previous sub-chapter mTOR was not inhibited for four different sets of 
initial conditions, the system reached the same steady state. The steady state levels for 
all the species are characteristic in normal rich nutrient conditions (high mTOR, low 
Atg1-Atg13 complex). 
In the next stage we add mTOR inhibition by rapamycin to the model 
(simulation 4.2.2). Specifically, we include reaction R8 which represents inhibition of 
mTOR by rapamycin (R). The product of the reaction is the inactive mTOR-rapamycin 
complex (mTOR-R). 
                                              RmTORRmTORR k _: 88 →+                                 (4.2.1) 
The rate expression for this reaction is: 
                                                        RmTORk ⋅⋅= 88υ                                           (4.2.1) 
Based on the reaction above we can describe the temporal change in 
concentration of the mTOR, rapamycin and mTOR-R complex by using an ordinary 
differential equation:  
                                                      
8
8
8
)(
)(
υ
υ
υ
=
−
−=
−=
dt
RmTORd
dt
dR
dt
mTORd
                                        (4.2.3) 
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The initial concentration of rapamycin for the simulation 4.2.2 is assumed to be 
100, the same as the total amount of mTOR (in all different species). This assumption 
was essential to ensure that rapamycin was able to inhibit all mTOR. Also we updated 
the model with the initial conditions of all the species obtained from the previous 
simulation (table 4.2.1). These concentrations represent the amount of the model 
components in normal cellular conditions. The parameter k8 for the added reaction was 
assumed to be 0.02 min-1 based on information that after rapamycin treatment the Atg1-
Atg13 complex appears in 10 minutes [Kamada et al., 2000]. 
We expected that the level of mTOR would decrease quite fast because 
rapamycin is its direct inhibitor. Further, the amount of Atg1-Atg13 complex should 
increase and after 10 minutes we expect a significant rise. 
The figure below represents the results of the simulation 4.2.2A.  
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Figure 4.2.5 Result of the simulation 4.2.2 for mTOR and Atg1-Atg13 complex 
behaviour after mTOR inhibition by rapamycin.  The plot displays the results of a 
simulation using the SBtoolbox for MatLab and shows the different behaviour of the 
mTOR and Atg1-Atg13 complex after rapamycin treatment (dose of rapamycin 100%). 
mTOR (red) decreases very quickly because of direct inhibition by rapamycin. Atg1-
Atg13 complex (blue) increases significantly within 10 minutes 
 
The new steady states after rapamycin treatment (100%) are: 
mTOR=4.42389·10-8 and Atg1-Atg13=90.9424. We can say that after rapamycin 
treatment, mTOR is completely inhibited and the Atg1-Atg13 complex increases up to 
~91%, which means that autophagy pathway can be induced. 
The figure plots the amount of mTOR and the Atg1-Atg13 complex against the 
dose of rapamycin.  
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Plot of mTOR (red) and Atg1-Atg13 complex (blue) against dose of rapamycin
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Figure 4.2.6 Dose dependent inhibition of mTOR kinase activity by rapamycin (red) 
and relationship between dose of rapamycin and Atg1-Atg13 complex (blue) creation. 
The plot represents the relation between the mTOR and Atg1-Atg13 complex on 
different doses of rapamycin. The plot displays the results of a simulation using the 
SBtoolbox for MatLab.With rising dose of rapamycin mTOR decreases while Atg1-
Atg13 complex increases. Dose dependent inhibition of mTOR by rapamycin has linear 
manner. 
 
 
We observed that even small doses of rapamycin (>10%) are able to inhibit mTOR 
activation. mTOR decreases in a linear manner with higher doses of rapamycin. We can 
also note that the creation of the Atg1-Atg13 complex is slightly delayed compared to 
the beginning of mTOR inhibition. Atg1-Atg13 complex has also bigger changes at the 
end of its curve, and reaches some level of saturation.  
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Figure 4.2.7 represents the kinetic behaviour of mTOR for different doses of 
rapamycin. The plot displays the results of a simulation using the SBtoolbox for 
MatLab.  
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Figure 4.2.7 Representation of the kinetic behaviour of mTOR in response to 
different doses of rapamycin. The plot represents the relation between mTOR in 
different doses of rapamycin and time. The plot displays the results of a simulation 
using the SBtoolbox for MatLab. We can observe that mTOR inhibition is very fast in all 
doses of rapamycin. 
 
The smaller the dose of rapamycin, the faster the steady state is reached and its value is 
closer to the basic level of the steady state for mTOR (55.55%). The higher dose of 
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rapamycin, the longer it takes to reach the steady state. mTOR’s response to different 
doses of rapamycin is rather linear, there is no significant threshold. 
Figure 4.2.8 represents the kinetic behaviour of the Atg1-Atg13 complex for 
different doses of rapamycin. The plot displays the results of a simulation using the 
SBtoolbox for MatLab. 
Atg1-Atg13 complex for different dose of rapamycin
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Figure 4.2.8 Representation of the kinetic behaviour of Atg1-Atg13 complex in 
response to different doses of rapamycin. The plot represents the relation between the 
Atg1-Atg13 complex for different doses of rapamycin and time. The plot displays the 
results of a simulation using the SBtoolbox for MatLab. We can observe that Atg1-
Atg13 complex creation is very fast in all doses of rapamycin. 
 
The smaller the dose of rapamycin, the lower the effect on the Atg1-Atg13 complex and 
the faster the steady state is reached. The higher the dose of rapamycin, the longer it 
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takes to reach the steady state. The response of Atg1-Atg13 complex to different doses 
of rapamycin is rather linear, there is no significant threshold. 
 
4.2.3 Starvation mimic by changing parameter k1 
In the next step we checked our initial model (as implemented in 4.2.1) in 
starvation conditions by changing the parameter k1. Parameter k1 which was calculated 
in chapter 4.1 is correct in normal rich nutrient conditions. By decreasing its value we 
can mimic starvation conditions. 
For the simulations 4.2.3 the model was implemented exactly the same as in 
4.2.1. This time to obtain plots we used MatLab syntax [SBtoolbox code was 
transferred to the MatLab code by Bartlomiej Tomiczek] and the parameter k1 was 
changed automatically. We were interested only in the starvation effect, therefore 
parameter k1 has only been changing in the range of (k1, 0), where k1=0.06716 min-1. 
Figure 4.2.9 plots the amount of mTOR and Atg1-Atg13 complex against different 
values of k1. 
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Plot of mTOR (red) and Atg1-Atg13 complex (blue) 
against different values of parameter k1
0
10
20
30
40
50
60
70
80
90
100
1E-101E-091E-080.00000010.0000010.000010.00010.0010.010.1
Value of k1
Am
o
u
n
t o
f m
TO
R 
an
d 
At
g1
-
At
g1
3 
co
m
pl
ex
 
[%
]
12.5%k1
80%k1
3.1%k1
0.05%k1
50%k1
 
Figure 4.2.9 Inhibition of mTOR kinase activity (red) by decreasing parameter k1 
(starvation mimic). Relation between changes in parameter k1 and Atg1-Atg13 
complex (blue) creation. Figure plots the mTOR and Atg1-Atg13 complex against 
different values of k1. The plot was made using simulations in MatLab. To obtain good 
autophagy response (high level of Atg1-Atg13 complex) parameter k1 has to be 
implemented as very low. With lower values of parameter k1 mTOR decreases while 
Atg1-Atg13 complex increases. 
 
We could observe that to induce autophagy (which is synonymous to an increase in the 
Atg1-Atg13 complex) we need to decrease parameter k1 by approximately 90-95%. It 
means that to get good autophagy response we need almost total starvation. mTOR 
decreases earlier and more rapidly than the Atg1-Atg13 complex increases. This fact 
allows us to conclude that mTOR has a buffer character. 
Figure 4.2.10 represents the kinetic behaviour of mTOR for different values of 
parameter k1. The plot was made using simulation in MatLab.  
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Figure 4.2.10 Representation of the kinetic behaviour of mTOR in response to 
different value of k1. The plot displays the results of a simulation using the SBtoolbox 
for MatLab. The figure plots mTOR against time for different values of k1. The level of 
mTOR decreases with decreasing of the parameter k1 value. We observe that mTOR 
inhibition is very slow for all values of k1, and the smaller k1 is the longer it takes. 
 
The higher value of k1 (closer to value k1=0.06716) the faster steady state is reached and 
the closer it is to the basic value of steady state for mTOR (55.55%). The smaller k1 
value, the longer it takes to reach steady state. 
 
Figure 4.2.11 represents the kinetic behaviour of Atg1-Atg13 complex for 
different values of parameter k1. The plot was made using simulation in MatLab. 
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Figure 4.2.11 Representation of the kinetic behaviour of Atg1-Atg13 complex in 
response to different value of k1. The plot was made using simulations in MatLab. The 
figure plots the Atg1-Atg13 complex against time for different values of k1. The level of 
the Atg1-Atg13 complex increases with decreasing of the parameter k1 value. We could 
observe that Atg1-Atg13 complex creation is very slow for small values of k1, which 
means that to get a high level of complex we have to starve the cell for a long time. 
 
The higher value of k1, the lower the effect on Atg1-Atg13 complex and the faster the 
steady state is reached. The smaller values of k1 the longer it takes to reach the steady 
state.  
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4.2.4 Conclusions for the initial model 
We successfully implemented the initial model which includes reactions 1 to 7 
(diagram 4.1). We checked the model in three different scenarios (all without feedback): 
4.2.1) in normal rich nutrient conditions, 4.2.2) in mTOR inhibition by rapamycin and 
4.2.3) in starvation mimic (by decreasing parameter k1). Simulation 4.2.1 provides the 
steady state values for all the species involved in the model in normal nutrient 
conditions. Simulations 4.2.2 and 4.2.3 lead to the induction of the autophagy pathway, 
due to mTOR inhibition. 
Simulation 4.2.1 was performed in the normal rich nutrient conditions, whereby we 
could get values of the steady states in this scenario. The obtained steady states are 
reasonable agreement with biological experimental data. In normal nutrient conditions 
the steady state for mTOR is 55.55%, while for the Atg1-Atg13 complex it is 16.66%. 
This illustrates that in rich medium conditions mTOR is active and the Atg1-Atg13 
complex remains on a low level. This partial amount of complex is required to maintain 
basal autophagy (Cvt pathway), which is necessary for turnover of long lived proteins. 
Based on the last two simulations (with mTOR inhibition by rapamycin and 
starvation mimic by decreasing k1) we can observe that induction of autophagy by 
rapamycin and by starvation has different kinetics, however the final results are similar: 
simulation 4.2.2 with rapamycin R(0)=100 and simulation 4.2.3 with 01 ≅k both gave 
the results of Atg1-Atg13 complex 90.94 % and mTOR ~10-8 % (table 4.2.2). We could 
also observe significant differences in the amount of rapamycin and the lack of nutrients 
which are needed for autophagy induction. To increase Atg1-Atg13 complex to ~20%, 
only 15-20% of rapamycin is needed, while during the starvation scenario almost 90-
95% of the k1 value has to be taken out to obtain the same results. 
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Table 4.2.2 List of the steady states values for the all species obtained in simulations 
4.2.1, 4.2.2 and 4.2.3. 
Species Steady states concentrations [%] in conditions: 
       normal               rapamycin            mimic starvation 
                            (100%)                        k1=0 
Simulation:  4.2.1           4.2.2                         4.2.3 
RhebGDP 16.71 0.000632913 100 
RhebGTP 27.74 0.00105058 0 
mTOR 55.55 4.42389·10-8 2.54474·10-8 
mTOR-FKBP38 44.44 0.00168349 100 
RhebGTP-FKBP38 55.55 99.9983 0 
Atg13_P 58.15 1.10634·10-7 6.36398·10-8 
Atg13 25.19 9.05764 9.05764 
Atg1 83.34 9.05764 9.05764 
mTOR-R - 99.9983 - 
Atg1-Atg13 16.66 90.9424 90.9424 
 
We also can say that the system has a fast response to rapamycin treatment – 
mTOR decreases after a maximum of 30 minutes (figure 4.2.7), while in starvation 
mimic (k1 manipulation) the response is quite slow and new steady states established in 
approximately 103 minutes (figure 4.2.10 and 4.2.11). This indicates that autophagy 
induction after rapamycin treatment is 100 times faster than induction due to nutrient 
starvation. 
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Possible reasons why there is such a big difference in the time of autophagy 
induction via rapamycin and starvation include: 
- rapamycin is a direct inhibitor of mTOR, which means that to block mTOR 
activation we can omit reactions 1 and 3 (according to the diagram 4.1) 
- to obtain mTOR inhibition by decreasing k1 (starvation mimic) we have to take 
into account reactions 1 and 3 (diagram 4.1), which take some time. 
In the normal rich nutrient conditions k1 is bigger than k2, which allows creation 
of active RhebGTP. Active RhebGTP plays the role of mTOR activator. In the starvation 
scenario k1 is smaller than k2, so production of new RhebGTP is blocked. All fraction of 
RhebGTP is in the complex with FKBP38, thus mTOR is activated. To inhibit mTOR in 
starvation conditions, we need its endogenous inhibitor FKBP38, thus dissociation of 
RhebGTP-FKBP38 is necessary. The reaction of dissociation, which takes some time, 
might slow down in general mTOR inhibition in starvation. In different words, to inhibit 
mTOR in starvation conditions, FKBP38 is needed. And because FKBP38 is in the 
complex with RhebGTP, it takes some time to dissociate this complex and obtain 
FKBP38 to block mTOR activity. 
 From the experimental data [Kamada et al., 2000] we know, that inhibition of 
mTOR after rapamycin is very fast (~5 minutes). Activation of autophagy by starvation 
is a much slower process and could a take few days [Chera et al., 2009]. We can 
conclude that the results of our initial model agree with experimental data. 
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Next, we could include into the model the total amino acid pool (4.3.1) and 
feedback from the amino acids created during autophagy pathway (4.3.2). 
In this chapter we present results of simulations with the fully implemented 
model of the autophagy pathway. First we wanted to test again the initial model but this 
time with the total amino acid pool implementation as a variable. In normal nutrient 
conditions, when the external amino acid supply is set to 100%, we expected the same 
results as in the previous simulations (4.2.1) with fixed k1. Next the feedback from the 
amino acids produced by autophagy was implemented as a contribution on the total 
amino acids pool.  
 
4.3.1 The total amino acid pool implementation 
Until now reaction 1 was implemented with a fixed k1 which takes into account 
normal nutrient conditions. The assumption before was that the external amino acid 
supply was constant and by manipulating k1 we could simulate changes in the external 
amino acids. Amino acids now should become a variable throughout the modelled time 
frame. 
Amino acids are continuously provided (external supply) and consumed by 
various reactions in the cell. We reduce these processes to the two reactions. 
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Figure 4.3.1 The total amino acid pool. Amino acids control the activation Rheb. The 
total amino acid pool is feed by an external amino acid supply. Amino acids are 
consumed by various reactions in the cell. 
 
The mass balance would be: 
                                               outAAinAAdt
AAd
__
)(
υυ −=                                         (4.3.1) 
where: 
AA_in – inflow of amino acids (for example external supply) 
AA_out – amino acids consumption by the cell (for example protein production, cell 
growth and division) 
In order to keep things as simple as possible, we consider a constant inflow of 
the amino acids: 
                                                   inAAinAA k __ =υ                                                     (4.3.2) 
and the consumption of the amino acids could be shown as follow: 
Total amino 
acids pool 
Amino acid 
consumption 
AA_out 
    GTP            GDP 
Amino acid supply 
AA_in 
kAA_in       kAA_out 
  k1 
  RhebGDP RhebGTP 
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                                               AAk outAAoutAA ⋅= __υ                                               (4.3.3) 
This is a simply assumption for the amino acids consumption to make sure that the cell 
reduces its amino acids consumption when the concentration is reduced and that the 
amino acids concentration will remain positive. 
A turnover of the amino acids in mammalian cells is 1% per hour [Mandelstam, 
1960], which gives the reaction constant kAA_out=0.0001666 min-1. To balance the total 
amino acid pool, the inflow of amino acids AA_in would have to be outAAinAA __ υυ = , 
which means that AAkk outAAinAA ⋅= __  and kAA_in=0.01666 min
-1
. 
 
Using the model in the case of the amino acid pool implementation, a simulation 
4.2.7 was made to check the correct software implementation of parameters kAA_in and 
kAA_out. We started the simulation with the same initial conditions as all previous 
simulations to see the behaviour of all of the species. We expected the same steady 
states values as in 4.2.1 simulation. 
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Figure 4.3.2 Result of the simulation 4.2.7 for all reactions involved in autophagy 
induction. The plot was made as a result of a simulation in SBtoolbox for MatLab and 
shows different behaviour of the individual species with set initial conditions. Blue bold 
line represents Atg1-Atg13 complex, which slowly decreases with mTOR (red bold line) 
increase. The simulation was similar to 4.2.1A, but in this scenario amino acids were 
implemented as a catalyser of reaction 1 (see figure 4.3.1).  
 
 
The steady states, which are the results of the simulation, are: RhebGDP=16.7091, 
RhebGTP=27.7356, mTOR=55.5553, mTOR-FKBP=44.4447, RhebGTP-FKBP=55.5553, 
Atg13-P=58.1475, Atg13=25.1944, Atg1=83.3419 and Atg1-Atg13=16.6581. These 
steady states values are exactly the same as in simulation 4.2.1. This result proves that 
the amino acids were implemented correctly. 
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4.3.2 The contribution of the autophagy feedback on the amino acid pool 
In the previous sub-chapters we implemented the initial model without the 
contribution of autophagy to the amino acid pool. In this part of the thesis the feedback 
loop has been added (figure 4.3.3), to modify the level of the total amino acid pool. The 
total amino acid pool is feed now with extra amino acids, which are produced by 
autophagy. The contribution of these amino acids is added to the model with a time 
delay and kinetic constant kF, which represents the strength of the feedback. We use 
here an idea of time delay for the part of the pathway from autophagosome nucleation to 
the degradation in lysosome and recycling.  
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Figure 4.3.3 Diagram of the full model of autophagy pathway. The total amino acid 
pool is maintained by two inflows: external amino acids supply and amino acids from 
the autophagy pathway. Amino acids control induction of the autophagy (reactions 
1+3+5+6). The result of the induction is the Atg1-Atg13 complex. The amount of the 
Atg1-Atg13 complex, with the time delay and strength kF composes feedback of the 
system. 
 
Now the total amino acids mass balance with the autophagy contribution aa_A 
would be 
                                   AaaoutAAinAAdt
AAd
___
)(
υυυ +−=                                        (4.3.4) 
Total amino 
acids pool 
Amino acid supply 
AA_in 
Amino acid from 
autophagy aa_A 
Amino acid 
consumption 
AA_out 
kAA_in 
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      kAA_out 
Reactions 
1+3+5+6 
Atg1-Atg13 
complex 
AUTOPHAGY 
(autophagosome 
formation+lysosome 
degradation) 
    DELAY 
kF 
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The process from the autophagosome nucleation and finishing with the 
lysosomal degradation and recycling is modelled as a time delay (20 minutes). Little is 
known about the part of the biochemical pathway from the autophagosome nucleation 
until fusion with the lysosome, but at least we know that it takes approximately 10 
minutes [Yoshimori, 2004]. The lysosomal pathway for the protein degradation 
(autophagy) we model as a pure time delay as well (additional 10 minutes time is set for 
degradation in the lysosome). The total time delay from the Atg1-Atg13 complex 
formation to the generation of the amino acids from the autophagy therefore was 20 
minutes. 
We made a simple assumption, that amount of the amino acids which are 
produced during the autophagy pathway, is proportional to the amount of Atg1-Atg13 
complex. Based on this assumption and figure 4.3.3 we could write a rate expression for 
the feedback reaction 
                                        delaytimeFF AtgAtgk _)13_1(⋅=υ                                     (4.3.5) 
The rate of the amino acids which are produced during autophagy is defined by 
the strength of the feedback constant kF.  
The part of the model with the time delay and feedback was implemented in the 
MatLab syntax by Bartlomiej Tomiczek. The reason for switching to the MatLab was 
that this software is more flexible and it allows more complex work, than SBtoolbox. 
The time delay was set to 20 minutes. Parameter kF was assumed to be 1, in order to get 
the proportional amount of aa_A to the Atg1-Atg13 complex.  In other words, we can 
present this relationship by 
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( _ ) ( 1_ 13)
( )F delay
d aa A d Atg Atgk
dt d t
= ⋅
                                   (4.3.6) 
 
The parameter kF is responsible for the velocity of the production of the amino 
acids during the autophagy pathway.  The feedback strength kF and the time delay are 
implemented in this way so that none of them influences the level of the amino acids 
production by the autophagy. The response of the system is not restricted by 
implementation method. Feedback modifies k1 and plays a role of the total amino acids 
pool modulator. 
Five simulations were conducted, in scenarios where the total amount of amino 
acids pool was set to: 100% (normal cellular conditions), 75%, 50%, 25% and 0% (the 
total starvation conditions). We wanted to check the influence of kF on the level of the 
amino acid production by autophagy, in different initial concentrations of the total 
amino acid pool. The plots below show the result of this simulation. Figure 4.3.4 shows 
the amount of the amino acids produced by autophagy as a result of the response to the 
total amino acid pool changes. Figure 4.3.5 shows the amount of the total amino acid 
pool with the contribution of autophagic amino acids. 
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Figure 4.3.4 Result of the simulation with the feedback for kF=1, for different initial 
values of the total amino acid pool AA(0). The plot was made as a result of a 
simulation in MatLab and shows the amount of amino acids produced in the autophagy 
pathway. Production of amino acids in this pathway acts as a response to starvation. In 
the scenario with 100% of the initial amino acid pool there is no autophagy respond 
(blue). In the case of starvation, when the amount of the initial amino acids is 0%, the 
production of the internal amino acids, as a response of the system, gives approximately 
the 8.5% (purple) steady state.  
 
We can observe that in the scenario when the amount of the initial amino acid pool is a 
maximum, there is no autophagy response (figure 4.3.4, line blue). In the case of full 
starvation the system gives approximately the 8.5 % level of the amino acids produced 
by autophagy. 
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Figure 4.3.5 Result of the simulation with the feedback for kF=1, for different initial 
values of the total amino acid pool AA(0). The plot was made as a result of a 
simulation in MatLab and shows the amount of the total amino acid pool with the 
contribution of autophagic amino acids. In the scenario with 100% of the initial amino 
acid pool, there is no autophagy response and the level of the AA pool stays the same 
(blue). In the case of starvation, when the amount of the initial amino acid pool is 0%, 
the production of the autophagic amino acids rises (purple).  
 
We can observe that in normal nutrient conditions (maximum AA(0)=100%) the level 
of the total amino acid pool reminds the same. Also for other conditions (AA(0)=75%, 
50%, 25%) changes in the total amino acid pool are small. In the starvation scenario, 
after 20 minutes time delay, due to autophagy, the amount of the amino acid pool 
increases and after approximately 140 minutes reaches the steady state.  
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We can conclude that autophagy, which occurs as a response to the starvation 
conditions, can replace some amount of the amino acids in the total amino acid pool.  
 
 In the next step we checked the model for different values of the parameter kF. 
This parameter represents the strength of the feedback and is responsible for the speed 
of the production of the amino acids in the autophagy pathway. In these simulations the 
influence of the different values of kF on the production of amino acids was 
investigated. We tried three values of parameter kF: 3, which represents a slightly 
stronger feedback than in the previous simulation; 5, which represents strong feedback; 
and 0.5 which represents weak feedback. The plots below show the results of these 
simulations (figure 4.3.6 – 4.3.11). Figures 4.3.6, 4.3.8 and 4.3.10 show the amount of 
amino acids produced by autophagy as a result of the response to the total amino acid 
pool changes. Figures 4.3.7, 4.3.9 and 4.3.11 show the amount of the total amino acid 
pool with the contribution of autophagic amino acids. 
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Figure 4.3.6 Result of the simulation with the feedback for kF=3, for different initial 
values of the total amino acid pool AA(0). The plot was made as a result of a 
simulation in MatLab and shows the amount of amino acids produced in the autophagy 
pathway. Production of the amino acids in this pathway acts as a response to 
starvation. In the scenario with 100% of the initial amino acid pool there is no 
autophagy response (blue). In the case of starvation, when amount of the initial amino 
acids is 0%, the production of the autophagic amino acids rises up very quickly and 
after few small oscillations and approximately 200 minutes reaches the 9% steady state 
(purple).  
 
 
We can observe that in the scenario when the amount of the initial amino acid pool is 
maximum, there is no autophagy response. In the case of full starvation the system 
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gives approximately the 9% level of amino acids produced by autophagy. In the first 
200 minutes, before system reaches the steady state, we can observe small oscillations. 
 
 
 
Figure 4.3.7 Result of the simulation with the feedback for kF=3, for different initial 
values of the total amino acid pool AA(0). The plot was made as a result of a 
simulation in MatLab and shows the amount of total amino acids pool with the 
contribution of autophagic amino acids. In the scenario with 100% of the initial amino 
acid pool, there is no autophagy response and the level of AA pool stays the same 
(blue). In the case of starvation, when the amount of the initial amino acid pool is 0%, 
the production of the autophagic amino acids rises up (purple) quickly at the beginning 
and after approximately 160 minutes reaches the steady state.  
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We can observe that in normal nutrient conditions (maximum AA(0)=100%) the level 
of the total amino acid pool remains the same. Also for other conditions (AA(0)=75%, 
50%, 25%) changes in the total amino acid pool are small. In the starvation scenario, 
after a 20 minute time delay, due to autophagy, the amount of the amino acid pool 
increases and after approximately 160 minutes reaches the steady state. In the first 160 
minutes, before it reaches the steady state we can observe small oscillations. 
 
In the next simulation we tested kF=5. The plots below show the result of these 
simulations (figure 4.3.8 and 4.3.9). Figure 4.3.8 shows the amount of amino acids 
produced by autophagy. Figure 4.3.9 shows the amount of the total amino acid pool 
with the contribution of autophagic amino acids. 
 
 
  
136
 
Figure 4.3.8 Result of the simulation with the feedback for kF=5, for different initial 
values of the total amino acid pool AA(0). The results plotted are from MatLab 
simulations and shows the amount of the amino acids produced in the autophagy 
pathway. Production of the amino acids in this pathway acts as a response to 
starvation. In scenario with 100% of the initial amino acid pool there is no autophagy 
response (blue). In the case of starvation, when amount of the initial amino acids is 0%, 
the production of the autophagic amino acids rises up very quickly and after many 
oscillations and approximately 400 minutes reaches the 9% steady state (purple).  
 
 
We can observe that in the scenario when the amount of the initial amino acid pool is 
maximum, there is no autophagy response. In the case of the full starvation the system 
gives approximately the 9% level of the amino acids produced by autophagy. In the first 
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400 minutes, before system reaches the steady state, we can observe many oscillations, 
which at the end reach the same steady state as in the scenario with kF=1 and kF=3. 
 
 
Figure 4.3.9 Result of the simulation with the feedback for kF=5, for different initial 
values of the total amino acid pool AA(0). The results plotted are from MatLab 
simulations and shows the amount of total amino acids pool with the contribution of 
autophagic amino acids. In scenario with 100% of the initial amino acid pool, there is 
no autophagy response and the level of AA pool stays the same (blue). In the case of 
starvation, when the amount of the initial amino acid pool is 0%, the production of the 
autophagic amino acids rises (purple) quickly at the beginning and after approximately 
350 minutes and many oscillations reaches the steady state.  
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We can observe that in normal nutrient conditions (maximum AA(0)=100%) the level 
of the total amino acid pool remains the same. Also for other conditions (AA(0)=75%, 
50%, 25%) changes in the total amino acid pool are small. In starvation scenario, after 
20 minutes time delay, due to autophagy, the amount of the amino acid pool increases 
and after approximately 350 minutes reaches the steady state. In the first 350 minutes, 
before it reaches the steady state we can observe many oscillations. 
 
We can conclude that in starvation conditions, with higher value of kF, the 
autophagic amino acids production is quicker (the first peak grows faster and higher – 
compare figures 4.3.4, 4.3.6 and 4.3.8). But also the higher kF the bigger oscillations 
occur in the system response. 
  
In the next simulation we tested kF=0.5. The plots below show the results of 
these simulations (figure 4.3.10 and 4.3.11). Figure 4.3.10 shows the amount of amino 
acids produced by autophagy. Figure 4.3.11 shows the amount of the total amino acid 
pool with the contribution of autophagic amino acids. 
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Figure 4.3.10 Result of the simulation with the feedback for kF=0.5, for different 
initial values of the total amino acid pool. The results plotted are from MatLab 
simulations and shows the amount of amino acids produced in autophagy pathway. 
Production of the amino acids in this pathway acts as a response to the starvation. In 
scenario with 100% of the initial amino acid pool there is no autophagy response 
(blue). In the case of starvation, when amount of the initial amino acids is 0%, the 
production of the autophagic amino acids rises and after approximately 300 minutes 
reaches the 7% steady state (purple).  
 
We can observe that in the scenario when the amount of the initial amino acid pool is 
maximum, there is no autophagy response. In the case of full starvation the system 
gives approximately 7% level of the amino acids produced by autophagy. This steady 
state is lower than in previous simulations, which reached 9%. Compared to figure 4.3.4 
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with kF=1, the time which the system takes to reach steady state is longer (300 minutes 
compare with 160 minutes on figure 4.3.4). 
 
 
Figure 4.3.11 Result of the simulation with the feedback for kF=0.5, for different 
initial values of the total amino acid pool AA(0). The results plotted are from MatLab 
simulations and shows the amount of total amino acid pool with the contribution of 
autophagic amino acids. In scenario with 100% of the initial amino acid pool, there is 
no autophagy response and the level of AA pool stays the same (blue). In the case of 
starvation, when the amount of the initial amino acid pool is 0%, the production of the 
autophagic amino acids rises (purple).  
 
We can observe that in normal nutrient conditions (maximum AA(0)=100%) the level 
of the total amino acid pool remains the same. Also for other conditions (AA(0)=75%, 
50%, 25%) changes to the total amino acid pool are small. In the starvation scenario, 
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after a 20 minute time delay, due to autophagy, the amount of the amino acid pool 
increases and after approximately 250 minutes reaches the steady state. Compare this 
result to figure 4.3.5 with kF=1, time which system takes for the achievement steady 
states is longer (250 minutes compare with 140 minutes on figure 4.3.5). 
 
BADBABA E#DD!DEEAEFB! "BFED
 We successfully obtained results from simulations of a fully implemented model 
with feedback on the total amino acid pool. In starvation, the total amino acid pool 
decreases dramatically. Autophagy occurs as a response to the starvation conditions.  
Based on the simulations, we can conclude that autophagy can replace some of the 
amino acids in the total amino acid pool. This contribution to the total amino acid pool 
is approximately 9%. 
The parameter kF is in control of the speed of the production of the amino acids 
during the autophagy pathway. Base on the simulations, we can conclude that in 
starvation conditions, with higher value of kF, the autophagic amino acids production is 
quicker. But the higher kF also results in bigger oscillations in the system response. 
Figure 4.3.12 below shows the influence of the different values of kF on amount of the 
amino acids produced by autophagy. 
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Figure 4.3.12 Result of the simulation with the feedback for kF=1 (blue), kF=2.5 
(green), kF=5 (red), kF=7.5 (light blue) and kF=10 (purple), in starvation (AA(0)=0). 
The plot was made as a result of a simulation in MatLab and shows the amount of the 
amino acids produced in autophagy pathway. The simulation was conducted in 
starvation conditions, for different values of kF. The bigger the value of kF, the faster 
and the higher production of the autophagic amino acids. Also bigger and more 
oscillation occur while we implement bigger value of kF. The contribution of the 
autophagy to the total amino acid pool is on the approximately 9% level. 
 
 
We can see that the contribution of the autophagy to the total amino acid pool reaches 
the 9% level. This value does not depend on the value of kF. We can also conclude that 
the lower value of kF has better dampening character. 
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%E BFEFABFED!EE0BAAF!DEEABA
 
This section describes model parameterization and implementation, and gives an 
explanation of methods which were used to obtain set of parameters. Our mathematical 
model is calibrated using published experimental data on the autophagy pathway in 
mammalian cells. 
All simulations were performed with a system of ordinary differential equations 
(ODE) which describe the biochemical reactions involved in signal transduction 
between amino acids and components of the mTOR-dependent autophagy induction 
pathway. The ordinary differential equations were based on mass action kinetics. The 
diagram, which represents all reactions included in the model, is provided in the chapter 
4 (figure 4.2). 
 
%E BFEFA EBFED!EE0BA
The kinetic constants for the first two reactions were derived from the two 
publications by Inoki et al and Marshall et al [Inoki et al., 2003 and Marshall et al., 
2009]. Based on the experimental data [Inoki et al., 2003] and by using the equation for 
exponential decay, we could calculate parameter k2. Another publication [Marshall et 
al., 2009], which was published during the course of this study, provided the value of 
k2. We calculated the average value of k2 from these two publications for use in our 
model. To calculate the parameter k1, we used again experimental data from Inoki et al. 
They provided the ratio of GTP/GDP- bound Rheb in living cells, which was 
formulated in the steady state condition. From the ordinary differential equations for the 
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first and second reaction we could obtain the equation for the ratio
2
1
k
k
Rheb
Rheb
GDP
GTP
= . 
From this equation k1 was calculated by GDP
GTP
Rheb
Rhebkk 21 = . The model was tested using 
SBtoolbox, rate expressions and calculated parameters. System Biology Toolbox for 
MatLab (version 1.8) is free software, developed as a suit of MATLAB scripts.  
The kinetic constants for the next two reactions were derived from the 
publications by Bai et al and Sato et al [Bai et al., 2007 and Sato et al., 2009]. Based on 
the experimental data [Sato et al., 2009] and using the equation for exponential decay, 
we could calculate half time for reaction R3. In this reaction we have two reactants and 
we can say that they behave like a second order process, in which the concentrations of 
the two reactants behave the same. For second-order reactions the half time is depended 
on the initial value of the reactant A.  
Based on this we could calculate the rate constant for reaction R3 as 
]38[
1
2
1
3 FKBPmTORt
k
−⋅
= .  
To derive parameter k
-3 for the next reaction we have studied publication by Bai et al. 
Based on their experimental data [Bai et al., 2007] and using again the equation for 
exponential decay, we could calculate the half time for this reaction. As the character of 
the reaction R
-3 is the same as the reaction R3, we could obtain parameter k-3 from the 
equation for the half time in the second-order reaction. This part of model was also 
tested using SBtoolbox, rate expressions and calculated parameters. 
       The kinetic constants for the next two reactions were derived from the 
publication by Kamada et al [Kamada et al., 2000]. Based on their experimental data 
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and using the equation for exponential decay, we could calculate parameter k5 and also 
the half time for reaction R4. Because reaction R4 has the nature of a second-order 
process, we could again calculate parameter k4 from the equation for the half time in the 
second-order reaction. This part of model was also tested using SBtoolbox, rate 
expressions and calculated parameters. 
 The kinetic constants for the next reactions were derived from the publication by 
Kamada et al [Kamada et al., 2000]. Parameters k6 and k-6 were fitted based on their 
experimental data. Parameter k6 was optimized by manual fitting. The aim was to get 
result which correlates with the experimental data, which shows the time of Atg1-Atg13 
complex creation after rapamycin treatment. Parameter k
-6 was also optimized by 
manual fitting that together with the rest of model components, could represent changes 
in the system, in the best way according to the experimental data. Parameter k7 was 
assumed to be equal to k4, based on the character of this reaction. Reaction R7 is a 
competitive reaction for reaction R4, where Atg13_P is produce, and both are controlled 
by mTOR. 
 
%E BFEFA EBFED!DEEABA
All simulations were performed with a system of ordinary differential equations 
(ODE). The ODEs were solved using SBtoolbox for MatLab and MatLab 7.3.0.267 
(R2006b). MatLab used ode15s solver for ordinary differential equations and dde23 
solver for delayed differential equations. SB code is available in appendix A and 
MatLab syntax in appendix B and C. 
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A system modelling autophagy is a new area of research. Current understanding 
of each step in this biochemical pathway is limited. The study of this mechanism is 
interesting in several aspects: autophagy plays an important role in physiological 
cellular processes, is a survival mechanism under external stress and is also connected 
with cancer and neurodegenerative diseases [Cuervo, 2004; Kondo et al., 2005; Levine, 
2007; Pan et al., 2008]. 
This work proposes a simple mathematical model of autophagy pathway as a 
system with feedback, which controls the level of the total amino acid pool. Feedback 
comes from the amino acids which are produced during the autophagy mechanism 
which is induced as a result of starvation or rapamycin treatment. 
There are limitations in the experimental literature with regards to the possible 
parameterisation of autophagy models. The research which is currently done on the 
autophagy pathway is poorly documented with quantitative data. There are no direct 
useful numbers or data, which can be used in systems biology (like half time of 
reaction, concentrations, etc.). The work in this field is often described in general terms, 
like "increasing", "decreasing", "less" or "more", and there is no really interest in 
specific numbers. Since systems biology has become more popular it is necessary to 
exchange information about the biological aspects and to provide helpful data. We can 
suggest at this point that the biochemical experiments might be more focused on 
quantitative results, which show a more detailed autophagy pathway.  Nevertheless, I 
was able to indirectly extract most of the parameters necessary for the model from the 
literature and published experimental data. The model, described here, is the first test of 
an autophagy model. It was implemented using parameters from the published 
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literature, some of which were estimated and optimized by manual fitting. This thesis 
details the model in order to serve as a reference for future work on the autophagy 
pathway. 
Still, the model is based on many additional assumptions and simplifications. In 
order to simplify our work, we did not include into our model other processes, which go 
on parallel in the cell. Also we did not take into calculations energy equivalents such as 
GTP, GDP, ATP and ADP. Initially we assumed that they are not limited. Amounts of 
reaction catalysers, such as TSC, TSTP and unknown phosphatase in reaction R5, we 
assumed as constants and we do not consider them in the equations.  Autophagy, in 
contrast to apoptotic cell death signalling, is not a well isolated signalling network. In 
fact, it is strongly linked with many other cellular signals and processes [Huett et al., 
2010]. A recent paper in Nature reported a proteomic analysis of the autophagy 
interaction network in human cells in normal nutrient conditions (Cvt pathway), 
uncovering a network of more than 750 interactions [Behrends et al., 2010]. 
Nevertheless, our initial model still reflects basic features of autophagy signalling. 
The initial simulations, which were performed in the normal nutrients scenario, 
show the behaviour of all model components involved in the autophagy induction. 
These simulations provided the values of the steady states for all species in normal 
nutrient conditions.  
We tested the initial model in two scenarios: when mTOR was inhibited by 
rapamycin and in starvation mimic conditions (decreasing parameter k1). Both of the 
scenarios lead to the induction of the autophagy pathway. In comparison, induction of 
autophagy by rapamycin and by starvation has different kinetics. However, the final 
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steady states are similar; the Atg1-Atg13 complex reaches approximately the 91% level 
in the full starvation scenario and after 100% rapamycin treatment. 
We observe that the system responded faster on rapamycin treatment. The new steady 
states established in 30 minutes, while in starvation after approximately 103 minutes. 
This indicates that autophagy induction after rapamycin treatment is 100 times faster 
than induction due to nutrient starvation. Possible reasons why there is such a big 
difference in the time of autophagy induction via rapamycin and starvation may be due 
to the character of both reactions. To obtain mTOR inhibition by starvation we have to 
start from reaction 1 and 3 (diagram 4.1). Because rapamycin is a direct inhibitor of 
mTOR we can omit these reactions. It means that we “save the time” by taking a 
shortcut. In the normal rich nutrient conditions k1 is bigger than k2. This allows creation 
of active RhebGTP. Afterwards, RhebGTP activates mTOR. In starvation conditions 
production of new RhebGTP is limited. The entire fraction of RhebGTP is in the complex 
with FKBP38, thus mTOR is active. To inhibit mTOR in the starvation scenario, we 
need its endogenous inhibitor FKBP38. That is why dissociation of RhebGTP-FKBP38 is 
necessary. Reaction of dissociation, which takes some time, might slow down in general 
mTOR inhibition in starvation. In other words, to inhibit mTOR in starvation 
conditions, its endogenous inhibitor FKBP38 is needed. And because FKBP38 is in the 
complex with RhebGTP, it takes some time to dissociate this complex and obtain 
FKBP38 to block mTOR activity. 
Kamada with his colleagues showed experimentally that inhibition of mTOR after 
rapamycin is very fast (~5 minutes) [Kamada et al., 2000]. In turn, activation of 
autophagy by starvation is a much slower process and could take even a few days 
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[Chera et al., 2009]. In conclusion, the results of our initial model correspond well to 
the experimental data. 
In the next step the feedback from the amino acids produced by autophagy was 
implemented as a contribution on the total amino acid pool. The feedback loop modifies 
k1 and regulates the level of the total amino acid pool. The contribution of the 
autophagic amino acids was implemented with a time delay and kinetic constant kF. 
Parameter kF represents the strength of the feedback and is responsible for the velocity 
of the production of the amino acids during the autophagy pathway. The amount of 
amino acids which are produced by the autophagy pathway is proportional to the 
amount of Atg1-Atg13 complex. 
During simulations, the influence of the different values of kF on the production of 
amino acids was investigated. We could observe that in starvation conditions the 
autophagic amino acids production was faster with higher value of kF. But also higher 
kF produced bigger oscillations in the system response. The lower values of kF had 
better dampening character. 
In general, we conclude that during starvation, autophagy is induced and this 
process can replace some amount of the amino acids in the total amino acid pool. This 
contribution on the total amino acid pool, amount to the 9% level. This value does not 
depend on the value of kF.  
From the results in chapter 4.2.3 when we tested model for starvation conditions, we 
know that 5-10% of the remaining amino acids (during starvation) is sufficient to 
prevent a significant increase in autophagy. The final simulations with the feedback 
showed that the autophagy contribution to the total amino acid pool is 9%. In general, 
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these results allow us to conclude that, the amount of amino acids produced in the 
autophagy pathway, as a response to starvation, is sufficient to keep basal Cvt pathway, 
unnecessarily autophagy induction. 
 The strength of the feedback kF is not reported in the experimental literature. 
However, Onodera and Ohsumi presented work on autophagy contribution to the 
maintenance of the amino acid pool [Onodera and Ohsumi, 2005], which might be 
helpful to obtain this value. They showed that the total amino acid pool decreased 
dramatically during the first 2 hours of starvation. Next, the pool was partially restored 
during 3-6 hours of starvation. Finally, the amino acid level reached a slightly lower 
level than first response. We can compare their result to our one oscillation plot (figure 
4.3.6) for the simulation with kF=3. Our value of the kF qualitatively correlates to their 
data. The results are only qualitatively comparable because the investigated species 
were different – Onodera and Ohsumi used yeasts, while our model is mostly validated 
based on results on mammalians. 
 In summary, this thesis presents a mathematical model of amino acids level 
control via the autophagy pathway as a feedback system. We tested the model in the 
case of mTOR inhibition by rapamycin and autophagy induction in starvation 
conditions. In the next step we suggest additional model testing in scenarios of protein 
overexpression or knock down. That requires experiments to validate model predictions. 
At the same time the model might assist already in experiments planning. 
We mentioned at the beginning of this chapter that our model does not include 
other reactions which occur in parallel with autophagy in the cell. However autophagy 
is linked to cell death signalling [Boya et al., 2005; Levine et al., 2008]. In mammalian 
cells there is the Bcl-2 protein family, which is implicated in the control of apoptosis 
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and autophagy [Levine et al., 2008]. As a further step we suggest simulations which 
might prove the connection of autophagy with apoptosis, which is already well 
described by system biological studies [Rehm et al., 2006; Huber et al., 2009]. 
Autophagy is also implicated in several human pathologies, such as different 
kinds of cancer, Parkinson's disease and Alzheimer's disease [Cuervo, 2004; Kondo et 
al., 2005; Levine, 2007; Pan et al., 2008]. In the future, the optimized, improved and 
fully validated model may help in anticancer research strategies and drag development.  
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!!EAF3
********** MODEL NAME 
Mathematical model of amino acids level control 
via autophagy as a feedback system. 
  
********** MODEL NOTES 
  
********** MODEL STATES 
d/dt(RhebGDP) = -v1+v2               
d/dt(RhebGTP) = v1-v2-v3+v33         
d/dt(mTOR) = v3-v33                  
d/dt(mTORxFKBP) = -v3+v33            
d/dt(RhebGTPxFKBP) = v3-v33          
d/dt(Atg13_P) = v4-v5+v7             
d/dt(Atg13) = -v4+v5-v6+v66          
d/dt(Atg1) = -v6+v66+v7              
d/dt(Atg1xAtg13) = v6-v66-v7         
d/dt(AA) = vAA_in-vAA_out            
                                     
RhebGDP(0) = 16.709173735229925      
RhebGTP(0) = 27.735575258098557      
mTOR(0) = 55.555251006671519         
mTORxFKBP(0) = 44.444748993328481    
RhebGTPxFKBP(0) = 55.555251006671519 
Atg13_P(0) = 58.147525934909623      
Atg13(0) = 25.19436723424695         
Atg1(0) = 83.341893169156577         
Atg1xAtg13(0) = 16.658106830843426   
AA(0) = 99.999400001200001 
  
********** MODEL PARAMETERS 
k1 = 0.00067159999999999995          
k2 = 0.040460000000000003            
k3 = 0.0033300000000000001           
k33 = 0.00133                        
k4 = 0.01498                         
k5 = 0.59899999999999998             
k6 = 0.0066499000000000003           
k66 = 0.005999                       
k7 = 0.01498                         
kAA_in = 0.0166666                   
kAA_out = 0.00016666660000000001 
  
********** MODEL VARIABLES 
  
********** MODEL REACTIONS 
v1 = k1*RhebGDP*AA                   
v2 = k2*RhebGTP                      
v3 = k3*(mTORxFKBP)*RhebGTP          
v33 = k33*(RhebGTPxFKBP)*mTOR        
v4 = k4*Atg13*mTOR                   
v5 = k5*(Atg13_P)                    
v6 = k6*Atg13*Atg1                   
v66 = k66*(Atg1xAtg13)               
v7 = k7*(Atg1xAtg13)*mTOR            
vAA_in = kAA_in                      
vAA_out = kAA_out*AA 
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!!EAF3+
%this file is the last version that I was able to write ('Bartomiej 
Tomiczek's code') 
%please mention in any papers while using this file  
  
function autofagia 
  
clear all;% necesery while using presistent variables  
ci=zeros(1,11);%input definition of the concentration 
out = [];%input definition of out  
d =[];%input definition of matrix d 
outt80 = [];%input definition  
par = [1]; %input definition of feedback kinetic constant 
multiplication 
Q = [];%input definition 
out1 = [];%input definition  
zmien = [1 0.75 0.5 0.25 0];%in this area you put the multiplication 
of the chosen parameter(you can use 10^zmien also) 
e = [];%input definition 
 for z = zmien  
%parametr z is being changed acording to zmien matrix elements so the 
chosen concentration can be changed         
ci(1) = 16.7103;   %RhebGDP 
ci(2) = 27.7349;   %RhebGTP 
ci(3) = 55.5548;   %mTOR 
ci(4) = 44.4452;   %mTORxFKBP 
ci(5) = 55.5548;   %RhebGTPxFKBP 
ci(6) = 58.1473;   %Atg13_P 
ci(7) = 25.1944;   %Atg13 
ci(8) = 83.3418;   %Atg1  
ci(9) = 16.6582;   %Atg1xAtg13 
ci(10) = 99.9999.*z;          %AA  
ci(11) = 0;          %AAB 
  
c = ci; 
  
%load('out80.mat'); %for loading variables  
  
 time = 200; %time of the simulation 
 tstep =0.1;%time step 
 licznik = 0;%counter of the number of solutions dine by dde 
 zas = 0;%definition of the variable 
 auto = zeros(1,time*tstep); %matrix that has a size of number of 
timesteps 
  
  
 opt = ddeset('RelTol', 1e-1, 'MaxStep', tstep);%options for the 
solver relative eror tolerance and time step  
  
  
 sol = dde23(@oligofago_MSC,[20 10],c,[0:tstep:time],opt,ci,par); 
%solve the simulation using oligofago_MSC script 
  
 e = sol.y;%concentration matrix 
  
 d = [d ; (e(11,:)) ];%AAB concentration matrix in different runs 
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 Q = [Q ; (e(11,:) + e(10,:)) ];%AA + AAB concentration matrix in 
different runs 
  
%  figure; 
  
% out80 = sol.y; 
% out80 
save('out80.mat'); 
  
 end 
  
 %figure,mesh((d)'); 
  
 figure,plot(sol.x,d);%plots AAB 
 figure,plot(sol.x,Q);%plots AA+AAb 
 %legend('100%AA','75%AA','50%AA','25%AA', '0%AA') 
 xlabel('time') 
 ylabel('AAB') 
  
end 
 
 
 
 

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!!EAF3
function out = oligofago_MSC(t,c,Z,ci,par) 
% global licznik zas time,ci,auto,licznik,zas 
S = [ % 1           2      3       4        5           6         7         8         9          
10     11       
      %RhebGDP   RhebGTP mTOR  mTORxFKBP RhebGTPxFKBP Atg13_P   Atg13    Atg1    
Atg1xAtg13     AA      AAB 
       -1           1      0       0        0           0         0         0         0           
0      0   %1 RhebGDP  + AA --> RhebGTP 
        1          -1      0       0        0           0         0         0         0           
0      0   %2 RhebGTP       --> RhebGDP 
        0          -1      1      -1        1           0         0         0         0           
0      0   %3 mTORxFKBP + RhebGTP --> RhebGTPxFKBP + mTOR 
        0           1     -1       1       -1           0         0         0         0           
0      0   %4 RhebGTPxFKBP + mTOR --> mTORxFKBP + RhebGTP 
        0           0      0       0        0           1        -1         0         0           
0      0   %5 Atg13 --> Atg13_P 
        0           0      0       0        0          -1         1         0         0           
0      0   %6 Atg13_P-->Atg13 
        0           0      0       0        0           0        -1        -1         1           
0      0   %7 Atg13 + Atg1 ---> Atg1xAtg13 
        0           0      0       0        0           0         1         1        -1           
0      0   %8 Atg1xAtg13 -->  Atg13 + Atg1  
        0           0      0       0        0           1         0         1        -1           
0      0   %9 Atg1xAtg13 -->  Atg13_P + Atg1 
        0           0      0       0        0           0         0         0         0           
1      0   %10 creation 
        0           0      0       0        0           0         0         0         0          
-1      0   %11 degradation 
        0           0      0       0        0           0         0         0         0           
0      1   %lag  
        0           0      0       0        0           0         0         0         0           
0     -1   %lag 
        0           0      0       0        0           0         0         0         0           
0     -1   %lag 
      ]; 
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k1 = 0.00067159999999999995;          
k2 = 0.040460000000000003;            
k3 = 0.0033300000000000001;           
k33 = 0.00133;                        
k4 = 0.01498;                         
k5 = 0.59899999999999998;             
k6 = 0.0066499000000000003;           
k66 = 0.005999;                       
k7 = 0.01498;                                      
kAA_out = 0.0001666666; 
kAA_in = kAA_out*ci(10); 
k11 = 1*par; 
  
cl = Z(:,1); 
  
  
v = zeros(14,1); 
v(1) = k1*c(1)*(c(10)+ par*c(11));  %k1*RhebGDP*AA 
v(2) = k2*c(2);   %k2*RhebGTP 
v(3) = k3*c(4)*c(2);%k3*(mTORxFKBP)*RhebGTP 
v(4) = k33*c(5)*c(3);%k33*(RhebGTPxFKBP)*mTOR 
v(5) = k4*c(7)*c(3);%k4*Atg13*mTOR 
v(6) = k5*c(6);%k5*(Atg13_P) 
v(7) = k6*c(7)*c(8);%k6*Atg13*Atg1 
v(8) = k66*c(9);%k66*(Atg1xAtg13) 
v(9) = k7*c(9)*c(3);%k7*(Atg1xAtg13)*mTOR  
v(10) = kAA_in;%kAA_in 
v(11) = kAA_out*c(10);%kAA_out*AA 
v(12) = k11*k6*cl(7)*cl(8);%k6*c(7)*c(8);%k6*Atg13*Atg1 
v(13) = k11*k66*cl(9);%k66*c(9);%k66*(Atg1xAtg13) 
v(14) = k11*k7*cl(9)*cl(3);%k7*c(9)*c(3);%k7*(Atg1xAtg13)*mTOR 
  
out = S'*v; 
% out 
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